Sponsored by

PuffItUp VapeFully Dynavap Vaposhop
  • Welcome to VaporAsylum! Please take a moment to read our RULES and introduce yourself here.
  • Feeling creative? Help create a new graphic for the asylum here and win a Dynavap NonaVong and Dynastash!!!
  • Did you know we have lots of smilies for you to use?
  • Need help navigating the forum? Find out how to use our features here.

Meds 700 Medicinal Uses for Cannabis sorted by Disease

momofthegoons

Vapor Accessory Addict
Staff member
Pages 201 - 205

Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21460248/abstract/Genetic_and_pharmacological_ inactivation_of_cannabinoid_CB1_receptor_inhibits_angiogenesis_

Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21785110

Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/22116907/abstract/17_Cannabidiol_as_an_anti_arr hythmic_the_role_of_the_CB1_receptors_

Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21459482/abstract/Regional_changes_in_type_1_c annabinoid_receptor_availability_in_Parkinson%27s_disease_in_vivo_

Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22079984

Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21029743

Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033

The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743

Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21145311

Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21764086

Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21718968

Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20817042/abstract/Increment_of_hypothalamic_2_ arachidonoylglycerol_induces_the_preference_for_a_high_fat_diet_via_activation_of_cannabinoid_1_rece ptors_
201

Type I cannabinoid receptor trafficking: all roads lead to lysosome. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21040297

Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21034788

Endocannabinoid CB1 receptors modulate visual output from the thalamus. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21773721

Cannabinoids and emotionality: a neuroanatomical perspective. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21827834

The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21887137

Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22034972

Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21813113

α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21843633

Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22077199

Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/18077184

In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21303859

Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22087025

ENDOGENOUS CANNABINOID SYSTEM REGULATES INTESTINAL BARRIER FUNCTION IN VIVO THROUGH CANNABINOID TYPE 1 RECEPTOR ACTIVATION (abst – 2011)

http://ajpgi.physiology.org/content/early/2011/11/28/ajpgi.00158.2011.abstract?sid=d420a7ad-54ba-4946- b1da-8bfe664eeec2
202

Impaired hippocampal glucoregulation in the cannabinoid CB(1) receptor knockout mice as revealed by an optimized in vitro experimental approach. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22155442

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/22007164/abstract/Endocannabinoid_system_and_ psychiatry:_in_search_of_a_neurobiological_basis_for_detrimental_and_potential_therapeutic_effects_

Sexually dimorphic effects of cannabinoid compounds on emotion and cognition.
(abst - 2011) http://www.unboundmedicine.com/medline/ebm/record/21991251/abstract/Sexually_dimorphic_effects_of _cannabinoid_compounds_on_emotion_and_cognition_

CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21340468/abstract/CB1_receptors_mediate_rimon abant_induced_pruritic_responses_in_mice:_investigation_of_locus_of_action_

The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21244428/abstract/The_cannabinoid_type_1_recep tor_carboxyl_terminus_more_than_just_a_tail_

Chronic Δ9-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21091643/abstract/Chronic_%CE%94%E2%81%B 9_tetrahydrocannabinol_treatment_in_rhesus_monkeys:_differential_tolerance_and_cross_tolerance_amon g_cannabinoids_

CB1 cannabinoid receptor mediates glucocorticoid effects on hormone secretion induced by volume and osmotic changes. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22211674

Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin- induced activation of central adrenomedullary outflow in rats. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21371452

Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. (full – 2011) http://onlinelibrary.wiley.com/doi/10.1002/biof.131/full

Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21513772/abstract/Association_between_a_cannab inoid_receptor_gene__CNR1__polymorphism_and_cannabinoid_induced_alterations_of_the_auditory_eve nt_related_P300_potential_

Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide

(abst – 2011)

http://www.jbc.org/content/286/33/29166.abstract?sid=2c3b88ec-b6e6-4245-a171-2e24c17b5e8b
203

Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22207189

Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 Receptor. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22044209

The genetic basis of the endocannabinoid system and drug addiction in humans (abst – 2011) http://jop.sagepub.com/content/early/2011/09/20/0269881111416689

The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743

Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/?tool=pubmed

JWH-018 and JWH-073: {Delta}9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects in Monkeys. (abst – 2012) http://www.unboundmedicine.com/medline/ebm/record/21965552/abstract/JWH_018_and_JWH_073:_%7 BDelta%7D9_Tetrahydrocannabinol_Like_Discriminative_Stimulus_Effects_in_Monkeys_

The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22093909

Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22087025

Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22005165

Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21937980

Extinction learning of rewards in the rat: is there a role for CB1 receptors? (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21519986

Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21701813

The cannabinoid receptor CB1 inverse agonist AM251 potentiates the anxiogenic activity

of urocortin I in the basolateral amygdala. (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/21736884
204

Cannabinoid Receptor Function is Altered by Nutrionally Deficient Diet (news – 2012)

http://www.examiner.com/medical-marijuana-in-philadelphia/cannabinoid-receptor-function-is-altered-by- nutrionally-deficient-diet

CBR - CB2 CANNABINOID RECEPTOR - no "high", activated by THC, Anandamide, 2 -AG Cannabinoid Receptor Ligands (full - no date)

http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html

Cannabis and cannabinoids: pharmacology and rationale for clinical use (abst – 1999)

http://pharmgkb.org/pmid/10575283

Immunomodulation by Cannabinoids is Absent in Mice Deficient for the Cannabinoid Cb(2) Receptor. (abst – 2000) http://www.sciencedirect.com/science/article/pii/S0014299900002119

Involvement of central and peripheral cannabinoid receptors in the regulation of heart resistance to arrhythmogenic effects of epinephrine. (abst - 2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11182823&dopt=abstrac tplus

Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1 (full - 2001) http://cancerres.aacrjournals.org/cgi/reprint/61/15/5784.pdf

Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors, Vanilloid Receptors, and Anandamide (full – 2002) http://www.cannabis-med.org/data/pdf/2002-01-3.pdf

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (full - 2002) http://bloodjournal.hematologylibrary.org/cgi/content/full/100/2/627?ijkey=eb71d6d7a06f311440761cfac6 a7d081bcc2771d

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? (abst - 2002) http://www.ncbi.nlm.nih.gov/pubmed/12550743

Lymphoma may be slowed by cannabis (news - 2002)

http://marijuana-ro.com/medical-usage/lymphoma-may-be-slowed-by-cannabis.html

Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains (full – 2003)

http://www.jneurosci.org/content/23/35/11136.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext= cannabinoid&searchid=1&FIRSTINDEX=80&resourcetype=HWCIT
205
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 206 - 210

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS (full - 2003) http://www.pnas.org/content/100/18/10529.full

Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN (full - 2003) http://www.jleukbio.org/cgi/content/full/75/3/453?maxtoshow=&hits=80&RESULTFORMAT=&fulltext= cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT

Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea- pigs by cannabinoid (CB2) receptor activation. (full - 2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574031/?tool=pubmed

Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats (full - 2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575196/?tool=pmcentrez

Cannabinoids and intestinal motility: welcome to CB2 receptors (full - 2004)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575197/

The Peripheral Cannabinoid Receptor CB2 and CD40 Are Novel Biological Markers

That Predict Outcome in Diffuse Large B-Cell Lymphoma of Elderly Patients.

(abst - 2004)

http://abstracts.hematologylibrary.org/cgi/content/abstract/104/11/3256?maxtoshow=&hits=80&RESULTF ORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=800&resourcetype=HWCIT

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation (full – 2005) http://www.springerlink.com/content/tq777102q4185073/fulltext.html

Cannabinoid receptor type 2 gene is associated with human osteoporosis (full - 2005)

http://hmg.oxfordjournals.org/cgi/content/full/14/22/3389?maxtoshow=&hits=80&RESULTFORMAT=&f ulltext=cannabinoid&searchid=1&FIRSTINDEX=400&resourcetype=HWCIT

Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist (full - 2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751228/?tool=pubmed

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor- independent mechanism (full - 2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089/?tool=pmcentrez

CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility. (full - 2005) http://www.iovs.org/content/46/6/1988.long

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice (full - 2005) http://www.nature.com/nature/journal/v434/n7034/full/nature03389.html
206

Identification and functional characterization of brainstem cannabinoid CB2 receptors. (full- 2005) http://www.sciencemag.org/content/310/5746/329.full

Marijuana May Grow Neurons in the Brain (news - 2005)

http://www.medpagetoday.com/Psychiatry/AnxietyStress/1934

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435344/?tool=pmcentrez

Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression (full - 2006) http://molpharm.aspetjournals.org/content/70/3/897.long

Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full - 2006) http://www.fasebj.org/cgi/content/full/20/13/2405?maxtoshow=&hits=10&RESULTFORMAT=&fulltext= cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HW CIT

In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013801/?tool=pubmed

Peripheral cannabinoid receptor, CB2, regulates bone mass (full - 2006)

http://www.pnas.org/content/103/3/696.full

Signaling pathways involved in the cardioprotective effects of cannabinoids. (full - 2006) http://www.jstage.jst.go.jp/article/jphs/102/2/155/_pdf

Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. (full – 2006) http://www.jbc.org/content/281/20/14192.long

Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2- Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice (full – 2006) http://www.jimmunol.org/content/177/12/8796.full

New Natural Noncannabinoid Ligands for Cannabinoid Type-2 (CB2) Receptors (abst - 2006) http://informahealthcare.com/doi/abs/10.1080/10799890600942674

Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production (abst - 2006) http://www.ingentaconnect.com/content/klu/mcbi/2006/00000283/F0020001/00002346

Evolutionary Origins of the Endocannabinoid System. (abst – 2006)

http://medical-journals.healia.com/doc/16434153/Evolutionary-origins-of-the-endocannabinoid-system
207

Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/19804131

Researchers from the Hebrew University Discover New Drug for Osteoporosis (news – 2006) http://news.softpedia.com/news/Researchers-From-the-Hebrew-University-Discover-New-Drug-for- Osteoporosis-15808.shtml

Activation of CB2 receptor attenuates bone loss in osteoporosis (news - 2006)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=210#2

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez

Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis (full - 2007) http://www.jneurosci.org/cgi/content/full/27/9/2396?maxtoshow=&hits=10&RESULTFORMAT=&fulltext =cannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype =HWCIT

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219542/?tool=pmcentrez

Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. (full - 2007) http://journals.lww.com/anesthesiology/pages/articleviewer.aspx?year=2007&issue=04000&article=00021 &type=abstract

Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/?tool=pmcentrez

In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219539/?tool=pmcentrez

Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637559/?tool=pmcentrez

The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819701/?tool=pmcentrez

CB2 receptors in the brain: role in central immune function (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219530/?tool=pmcentrez
208

Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/?tool=pmcentrez

Potential role for CB2 selective ligands as immunosuppressive agents (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864948/?tool=pmcentrez

Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219541/?tool=pmcentrez

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (full - 2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2189767&tool=pmcentrez

CB2 cannabinoid receptors promote mouse neural stem cell proliferation. (abst – 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17328768

Cannabinoids for the treatment of inflammation. (abst - 2007)

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=17520866&dopt=abstrac tplus

Cannabinoid CB2 receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux (abst - 2007) http://www.ncbi.nlm.nih.gov/pubmed/17643417

Role of cannabinoid CB2 receptors in glucose homeostasis in rats (abst – 2007)

http://www.sciencedirect.com/science/article/pii/S001429990700249X

The cannabinoid CB(2) receptor: a good friend in the gut. (abst – 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17727390

Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans (abst – 2007) http://pharmgkb.org/pmid/17189959

Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17205329

CB2 receptors in reproduction (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219526/

Cannabinoid CB2 receptors in human brain inflammation (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219537/

Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592089/?tool=pmcentrez
209

Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor (full - 2008) http://endo.endojournals.org/cgi/content/full/149/11/5619?maxtoshow=&hits=80&RESULTFORMAT=&f ulltext=cannabinoid&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9- tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/

The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking INVOLVEMENT IN THE PATHOGENESIS OF AN ANIMAL MODEL OF MULTIPLE SCLEROSIS (full - 2008) http://www.jbc.org/content/283/19/13320.long

Cannabinoid receptors and the regulation of bone mass (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219540/?tool=pmcentrez

Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats (full - 2008) http://jpet.aspetjournals.org/content/327/2/584.full#content-block

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219542/

Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases (full – 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267750/?tool=pubmed

Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain (full - 2008) http://www.jneurosci.org/cgi/content/full/28/46/12125

Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494728/?tool=pubmed

Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. (full – 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/?tool=pubmed

Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376822/?tool=pmcentrez

Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats (full - 2008) http://jpet.aspetjournals.org/content/324/2/475.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext= cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block
210
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 211 - 215

Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219536/?tool=pmcentrez

CB2 receptors as new therapeutic targets for liver diseases. (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219531/?tool=pubmed

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. (full - 2008) http://www.jbc.org/content/283/19/13320.long

Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. (full - 2008) http://www.jneurosci.org/cgi/content/full/28/46/12125

Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. (full – 2008) http://www.fasebj.org/content/22/10/3685.long

Role of CB2 receptors in neuroprotective effects of cannabinoids. (abst - 2008)

http://www.ncbi.nlm.nih.gov/pubmed/18291574

Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption. (abst - 2008) http://www.ncbi.nlm.nih.gov/pubmed/18991890

Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18068305

New Cannabis-Like Drugs Could Block Pain Without Affecting Brain, Says Study (news - 2008) http://www.sciencedaily.com/releases/2008/09/080912091728.htm

Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731878/?tool=pmcentrez

Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke. (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855650/?tool=pubmed

Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768535/?tool=pmcentrez

The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi‘s sarcoma cells in vitro (full - 2009) http://science.iowamedicalmarijuana.org/pdfs/cancer/Luca et al 2009 19539619.pdf

The cannabinoid receptor 2 is critical for the host response to sepsis. (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763235/?tool=pubmed
211

Endocannabinoids and Their Receptors as Targets for Obesity Therapy (full - 2009) http://endo.endojournals.org/cgi/content/full/150/6/2531#top

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)- Methanandamide and JWH-015: Involvement of CB2 (full - 2009) http://www.nature.com/bjc/journal/v101/n6/full/6605248a.html

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. (full - 2009) http://onlinelibrary.wiley.com/doi/10.1002/ibd.20960/full

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity (full - 2009) http://brain.oxfordjournals.org/content/132/11/3152.long

Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19115380

Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19897083

Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/20590564

Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19237169

The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19908944

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19505450?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPa nel.Pubmed_RVDocSum&ordinalpos=18

Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications (abst – 2009) http://pharmgkb.org/pmid/19897083

CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19162037

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19332079
212

The influence of cannabinoid CB2 receptor in adult rat mesenchymal stem cell viability (abst – 2009) http://www.physoc.org/custom2/publications/proceedings/archive/article.asp?ID=Proc Physiol Soc %2015PC171

The role of CB2 cannabinoid receptor and Leptin in hepatic fibrosis via lymphocyte alterations and HSC phagocytosis (abst – 2009) http://www.docstoc.com/docs/76792678/The-role-of-CB2-cannabinoid-receptor-and-Leptin-in-hepatic-

Cannabis may apparently stop prostate cancer growth (news - 2009)

http://www.healthjockey.com/2009/08/21/cannabis-may-apparently-stop-prostate-cancer-growth/

The cannabinoid system: cannabinoids and receptors (news – 2009)

http://www.examiner.com/health-science-in-vancouver/the-cannabinoid-system-cannabinoids-and- receptors

CB2: a cannabinoid receptor with an identity crisis. (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931549/?tool=pubmed

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. (full – 2010) http://www.fasebj.org/content/24/3/788.long

Brain CB2 Receptors: Implications for Neuropsychiatric Disorders (full – 2010)

http://www.mdpi.com/1424-8247/3/8/2517/pdf

Patent 7741365 Peripheral cannabinoid receptor (CB2) selective ligands (full – 2010)

http://www.patentstorm.us/patents/7741365/fulltext.html

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869084/?tool=pubmed

Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis (full - 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486/?tool=pubmed

A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands.
(abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813

Brain cannabinoid CB2 receptor in schizophrenia. (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/19931854

The cannabinoid receptor type 2 is time-dependently expressed during skeletal muscle wound healing in rats (abst - 2010) http://www.ncbi.nlm.nih.gov/sites/pubmed
213

Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894

Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19931541

Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132591/?tool=pubmed

Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846023/?tool=pubmed

Consider the CB(2) Receptor (article – 2010)

http://www.wellsphere.com/drug-addiction-article/consider-the-cb-2-receptor/1164631

Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20863899

The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies. (abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20236042/abstract/The_development_of_cannabin oid_CBII_receptor_agonists_for_the_treatment_of_central_neuropathies_

Role of the endocannabinoid system in alcoholic liver disease. (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/21525760

Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery (abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20718749/abstract/Interaction_between_anandami de_and_sphingosine_1_phosphate_in_mediating_vasorelaxation_in_rat_coronary_artery_

Studies demonstrate analgesic properties of synthetic cannabinoid (news – 2010)

http://www.news-medical.net/news/20100702/Studies-demonstrate-analgesic-properties-of-synthetic- cannabinoid.aspx

Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice (full – 2011) http://www.nature.com/npp/journal/v36/n7/full/npp201134a.html

Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice (full– 2011)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082575/?tool=pubmed

Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early

Atherosclerosis in LDL Receptor Deficient Mice. (full – 2011)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?tool=pubmed
214

WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells. (full – 2011) http://www.nature.com/cddis/journal/v2/n11/full/cddis2011106a.html

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930808/?tool=pubmed

New blood brothers: the GPR55 and CB2 partnership (full – 2011)

http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201177a.html

Functional selectivity in CB2 cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB2 ligands. (full – 2011) http://molpharm.aspetjournals.org/content/early/2011/11/07/mol.111.074013.long

The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198780/?tool=pubmed

Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168464/?tool=pubmed

Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities (full – 2011)

http://www.jpbsonline.org/article.asp?issn=0975- 7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha

Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis. (full – 2011) http://www.jstage.jst.go.jp/article/bpb/34/7/1090/_pdf

Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21875957

Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors. (abst - 2011) http://marijuana.researchtoday.net/archive/8/1/3517.htm

The role of central CB2 cannabinoid receptors on food intake in neonatal chicks. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21927979

Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21550725/abstract/Self_medication_of_a_cannabin oid_CB_2__agonist_in_an_animal_model_of_neuropathic_pain_

Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21810593
215
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 216 - 220

The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21447627/abstract/The_Type_2_Cannabinoid_Rec eptor_Regulates_Bone_Mass_and_Ovariectomy_Induced_Bone_Loss_by_Affecting_Osteoblast_Differenti ation_and_Bone_Formation_

GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.
(abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21467997/abstract/GPR55_regulates_cannabinoid_ 2_receptor_mediated_responses_in_human_neutrophils_

Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21063029

Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21873455

Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21309057/abstract/Win_55212_2_reduces_cardiac _ischaemia_reperfusion_injury_in_zucker_diabetic_fatty_rats:_role_of_cb2_receptors_and_cardiac_inos/e nos_expression_

CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity (abst – 2011) http://jop.sagepub.com/content/early/2011/03/29/0269881111400652.abstract?maxtoshow=&hits=80&RES ULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&sortspec=date&resourcetype=H WCIT

Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6- hydroxydopamine. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20980074

Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21658778

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21295074

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice (abst – 2011)

http://www.nature.com/neuro/journal/vaop/ncurrent/full/nn.2874.html

G-protein coupled receptors regulating cough. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21727026

Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
216

Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21884703

Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21855337

Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21430651

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/22007164/abstract/Endocannabinoid_system_and_ psychiatry:_in_search_of_a_neurobiological_basis_for_detrimental_and_potential_therapeutic_effects_

Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22074629

Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21063029

Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice (abst - 2011) http://www.unboundmedicine.com/medline/ebm/record/21771590/abstract/Antinociceptive_effects_induce d_through_the_stimulation_of_spinal_cannabinoid_type_2_receptors_in_chronically_inflamed_mice_

Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507

Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20597071/abstract/Beneficial_paracrine_effects_of _cannabinoid_receptor_2_on_liver_injury_and_regeneration_

Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22119709

CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (abst – 2011) http://www.jbc.org/content/287/2/1198.abstract?sid=2c3b88ec-b6e6-4245-a171-2e24c17b5e8b

Behavioral effects of pulp exposure in mice lacking cannabinoid receptor 2. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22152627

Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22020035
217

Cannabinoid CB(2) receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21671903

Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6- hydroxydopamine. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/20980074

CBR – GPR-40 CANNABINOID RECEPTOR - activated by GW1100, TAK-875

The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse. (abst – 2005) http://medical-journals.healia.com/doc/16054069/The-FFA-receptor-GPR40-links-hyperinsulinemia- hepatic-steatosis-and-impaired-glucose-homeostasis-in-mouse

Gpr40 Gene Expression in Human Pancreas and Insulinoma. (abst – 2005)

http://medical-journals.healia.com/doc/16289108/GPR40-gene-expression-in-human-pancreas-and- insulinoma

Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751878/?tool=pubmed

Expression of the Gene for a Membrane-bound Fatty Acid Receptor in the Pancreas and Islet Cell Tumours in Humans: Evidence for Gpr40 Expression in Pancreatic Beta Cells and Implications for Insulin Secretion. (abst – 2006)

http://medical-journals.healia.com/doc/16525841/Expression-of-the-gene-for-a-membrane-bound-fatty- acid-receptor-in-the-pancreas-and-islet-cell-tumours-in-humans-evidence-for-GPR40-expression-in- pancreatic-beta-cells-and-implications-for-insulin-secretion

Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose- dependent insulin secretion and reduce blood glucose in mice. (full – 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494688/?tool=pubmed

Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671040/?tool=pubmed

Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat. (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19217448

Takeda moves potential first-in-class diabetes drug into phase III (news – 2011)

http://www.inpharm.com/news/166980/takeda-diabetes-tak-875-phase-iii
218

CBR - GPR55/ CB3 CANNABINOID RECEPTOR

Activated by THC, CBD,O-1602, PEA, 2-AG, Anandamide Cannabinoid Receptor Ligands (full - no date)

http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. (abst - 1999) http://www.ncbi.nlm.nih.gov/pubmed/9931487

Evolutionary Origins of the Endocannabinoid System. (abst – 2006)

http://medical-journals.healia.com/doc/16434153/Evolutionary-origins-of-the-endocannabinoid-system

GPR55: a new member of the cannabinoid receptor clan? (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095104/?tool=pubmed

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190033/?tool=pubmed

GPR55 and the vascular receptors for cannabinoids. (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed

GPR55 is a novel cannabinoid receptor (full - 2007) (needs registration)

http://www.biomedcentral.com/1471-2210/7/S2/A3

Novel cannabinoid receptors (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190013/?tool=pmcentrez

GPR55: signaling pathways and functions (abst - 2007) (needs registration)

http://www.biomedcentral.com/1471-2210/9/S2/A3

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268199/?tool=pubmed

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737440/?tool=pubmed

Receptors for acylethanolamides-GPR55 and GPR119. (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed

Is GPR55 an anandamide receptor? (abst - 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19647110

The enigmatic pharmacology of GPR55. (abst - 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19233486.
219

Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. (full - 2009) http://www.jbc.org/content/284/43/29817.full?sid=ec54c280-2526-4d1b-ab9f-73a1ca683a5e

Pharmacological characterization of GPR55, a putative cannabinoid receptor.
(abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20298715/abstract/Pharmacological_characterizati on_of_GPR55_a_putative_cannabinoid_receptor_

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21080464

GPR55: Current Knowledge and Future Perspectives of a Purported "Type-3" Cannabinoid Receptor. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20166924

Cannabinoids and the gut: new developments and emerging concepts (abst - 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20117132

A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20590578

Cannabinoids and Bone: Friend or Foe? (abst - 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20532878

Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20649563

Screening for Selective Ligands for GPR55. (full – 2011)

http://www.ncbi.nlm.nih.gov/books/NBK66153/

New blood brothers: the GPR55 and CB2 partnership (full – 2011)

http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201177a.html

What is the natural ligand of GPR55? (abst – 2011)

http://jb.oxfordjournals.org/content/149/5/495.short?rss=1

Pharmacology, Signaling and Physiological Relevance of the G Protein-coupled Receptor 55. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21907912

GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.
(abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21467997/abstract/GPR55_regulates_cannabinoid_ 2_receptor_mediated_responses_in_human_neutrophils_

The GPCR - associated sorting protein 1 regulates ligand-induced downregulation of GPR55. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21718301
220
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 221 - 225

Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21464819

The novel cannabinoid receptor GPR55, inhibits cholangiocarcinoma growth
(abst – 2011) http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/1117.3?maxtoshow=&hits=80 &RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcety pe=HWCIT

Modulation of the novel cannabinoid receptor - GPR55 - during rat fetoplacental development (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21497900

A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21726355

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21744421

The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21683763

A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21885477

Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21907912

Functional polymorphism in the GPR55 gene is associated with anorexia nervosa. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20506567

The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20838378

CBR - GPR109 CANNABINOID RECEPTOR

Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells (full – 2011) http://www.jci.org/articles/view/41651?search[abstract_text]=&search[article_text]=cannabinoid&search[a uthors_text]=&search[fpage]=&search[issue]=&search[title_text]=&search[volume
221

CBR - GPR119 CANNABINOID RECEPTOR
- activated by PEA, OEA

A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. (full – 2007) http://endo.endojournals.org/content/148/6/2601.long

GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268073/?tool=pmcentrez

Receptors for acylethanolamides-GPR55 and GPR119. (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed

N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119. (full – 2010) http://mend.endojournals.org/content/24/1/161.long

GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21094910

Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20937249

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20816753

GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (abst – 2011) http://endo.endojournals.org/content/152/2/374.abstract?sid=c77be354-b90f-4368-9bb3-fea533824b24

The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22029844

CELIAC DISEASE

Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17396241

Hemp: A replacement for common food allergens? (news - 2009)

http://www.examiner.com/x-20151-Manchester-Gluten-Free-Examiner~y2009m8d25-Hemp--A- replacement-for-common-food-allergens
222

Celiac Disease and Medical Marijuana (news – 2009)

http://pharmcannabis.com/?p=14

Abnormal anandamide metabolism in celiac disease. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/22209002

CEREBRAL PALSY

Treatment of human spasticity with delta 9-tetrahydrocannabinol. (abst – 1981)

http://www.ncbi.nlm.nih.gov/pubmed/6271839

Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor- mediated excitotoxic damage. (full – 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751782/?tool=pubmed

Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and eview of the literature. (abst – 2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=157&

CESAMET - see NABILONE

CHEMICAL COMPOSITION

Compounds found in Cannabis Sativa (list- no date)

http://www.ukcia.org/research/cannabis-compounds.htm

The active principles of Cannabis indica resin. I. (full - 1938)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1264344/pdf/biochemj01029-0136.pdf

The Active Principles of Cannabis and the Pharmacology of the Cannabinols (full - 1940) http://www.ukcia.org/research/TherapeuticPotentialMedicalUses.php
HEMP AS A MEDICAMENT : Properties of isolated substances

http://www.greenpassion.org/showthread.php?p=306831#post306831

HEMP AS A MEDICAMENT : Survey of clinical experiences

http://www.greenpassion.org/showthread.php?p=306835#post306835

Recent Developments in Cannabis Chemistry (full - 1972)

http://www.onlinepot.org/medical/Dr_Tods_PDFs/s5_6.pdf

(full - 1955) (full - 1955)
223

A SIMPLE METHOD FOR DEMONSTRATING TETRAHYDROCANNABINOLS IN FRESH OR FIXED FROZEN SECTIONS (full – 1972) http://jhc.sagepub.com/content/20/10/827.full.pdf+html

Water-soluble derivatives of 1 -tetrahydrocannabinol. (abst - 1972)

http://www.ncbi.nlm.nih.gov/pubmed/5043146

The chemistry and biological activity of cannabis (news - 1972)

http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1972-01-01_2_page005.html

Cannabinoid Phenotypes in Cannabis sativa (abst - 1973)

http://www.nature.com/nature/journal/v245/n5421/abs/245147a0.html

Constituents of Cannabis sativa L. II: Absence of cannabidiol in an african variant (abst – 1975) http://onlinelibrary.wiley.com/doi/10.1002/jps.2600620214/abstract

Constituents of Cannabis sativa L. VIII: Possible biological application of a new method to separate cannabidiol and cannabichromene. (abst - 1975) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=1151651&dopt=abstract plus

Cannabinoid Profile and Elemental Uptake of Cannabis sativa L. as Influenced by Soil Characteristics (abst - 1975) http://agron.scijournals.org/cgi/content/abstract/67/4/491?maxtoshow=&hits=80&RESULTFORMAT=&fu lltext=marihuana&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT

Ganja in Jamaica : Appendix III – ―Laboratory Analyses of Ganja Samples.‖ (book – 1976) http://www.cifas.us/cannabis/PDFs/OCRGanjainJamaica.pdf

Cannabinoid patterns in seedlings of Cannabis sativa L. and their use in the determination of chemical race. (abst – 1977) http://www.ncbi.nlm.nih.gov/pubmed/19599

Cannabinoid formation in Cannabis sativa grafted inter-racially, and with two Humulus species (abst - 1975) https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1978-01-01_1_page007.html

Responses of Greenhouse-grown Cannabis sativa L. to Nitrogen, Phosphorus, and Potassium (abst - 1977) http://agron.scijournals.org/cgi/content/abstract/69/5/832?maxtoshow=&hits=80&RESULTFORMAT=&fu lltext=marihuana&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT

The decomposition of acidic and neutral cannabinoids in organic solvents. (abst – 1977)

http://www.ncbi.nlm.nih.gov/pubmed/17692

CHEMOTAXONOMY OF CANNABIS 1. CROSSBREEDING BETWEEN CANNABIS SATIVA AND C. RUDERALIS, WITH ANALYSIS OF CANNABINOID CONTENT (full - 1978) http://www.cannabase.com/cl/bcga/journals/Beutler1979/Beutler1979.html
224

Influence of photoperiodism on cannabinoid content of Cannabis sativa L. (abst – 1978)
http://www.ncbi.nlm.nih.gov/pubmed/248289

An investigation of procedures reported to increase potency of marijuana: a chemical analysis and psychological interpretation. (abst – 1978) http://www.ncbi.nlm.nih.gov/pubmed/721338

Interrelationships of glandular trichomes and cannabinoid content. I: Developing pistillate bracts of Cannabis sativa L. (Cannabaceae). (full – 1981) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1981-01-01_3_page007.html

Interrelationships of glandular trichomes and cannabinoid content II. Developing vegetative leaves of Cannabis sativa L. (Cannabaceae) (full - 1981) http://www.cannabase.com/cl/bcga/journals/Turner1981b/turner1981b.html

Chemataxonomic researches in higher plants. XV Carotenoid and chlorophyll pigments in the leaves of Cannabis sativa L. (full - 1981) http://notulaebotanicae.ro/nbha/article/view/144/138

Constituents of Cannabis sativa L., XX: the cannabinoid content of Mexican variants grown in Mexico and in Mississippi, United States of America (full - 1982) http://www.cannabase.com/cl/bcga/journals/Turner1982a/turner1982a.html

Constituents of Cannabis sativa, XXV. Isolation of two new dihydrostilbenes from a Panamanian variant. (abst – 1984) http://www.ncbi.nlm.nih.gov/pubmed/6481358

Cannabinoid content of cannabis grown on the Danish island of Bornholm. (abst – 1985) http://www.ncbi.nlm.nih.gov/pubmed/3011164

Identification of a New Chemotype in Cannabis sativa: Cannabigerol - Dominant Plants, Biogenetic and Agronomic Prospects (abst – 1987)

https://www.thieme-connect.com/DOI/DOI?10.1055/s-2006-962705

Oral vs. Inhaled Cannabinoids for Nausea/Vomiting from Cancer Chemotherapy (full - 1988) http://www.medmjscience.org/Pages/science/pierson.html

Histochemical detection of hemp trichomes and their correlation with the THC content. (abst - 1988) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=2855383&dopt=abstract plus

Characterization of the lipophilicity of natural and synthetic analogs of delta 9- tetrahydrocannabinol and its relationship to pharmacological potency.

(abst - 1990)

http://jpet.aspetjournals.org/content/255/2/624.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=marihuana&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT

Cannabinoid acids analysis. (abst – 1992) http://www.ncbi.nlm.nih.gov/pubmed/1503600
225
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 226 - 230

Some features of Cannabis plants grown in the United Kingdom from seeds of known origin. (abst - 1992) http://www.unboundmedicine.com/medline/ebm/record/1361557/abstract/

Chemical ecology of Cannabis (full - 1994) http://www.hempfood.com/Iha/iha01201.html The Volatile Oil Composition of Fresh and Air-Dried Buds of Cannabis sativa

(full – 1996) http://www.cannabis-science.com/papers/oil comp cannabis.pdf

Effect of nitrogen on tetrahydrocannabinol (THC) content in hemp (Cannabis sativa L.) leaves at different positions (full - 1997) http://www.internationalhempassociation.org/jiha/jiha4207.html

Essential Oil of Cannabis sativa L. Strains (full – 1997)

http://www.cannabis-science.com/papers/essentialoilcsativa.html

Capillary electrochromatography of cannabinoids. (abst – 1998)

http://www.ncbi.nlm.nih.gov/pubmed/11013726

Medical Cannabis Potency Testing Project (full - 1999)

http://www.maps.org/news-letters/v09n3/09320gie.html

Hemp Seed Oil : The Wonder Oil For the New Millennium (news - 1999)

http://www.ukcia.org/research/Happi/HempSeedOilTheWonderOilForTheNewMillennium.htm

Advantages of polypharmaceutical herbal cannabis compared to single ingredient, synthetic tetrahydrocannabinol (full - 2000) http://www.cannabis-science.com/papers/cannabis terpenes.pdf

Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation. (abst – 2000) http://www.ncbi.nlm.nih.gov/pubmed/10807034

Characterisation of cannabis plants phenotypes from illegal cultivations in Crete
(abst - 2000) http://www.ncbi.nlm.nih.gov/pubmed/10961025?ordinalpos=89&itool=EntrezSystem2.PEntrez.Pubmed.Pu bmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

GC-MS analysis of the total delta9-THC content of both drug- and fiber-type cannabis seeds. (abst – 2000) http://www.ncbi.nlm.nih.gov/pubmed/11110027

Differential effects of medical marijuana based on strain and route of administration : A three-year observational study (full - 2001) http://www.ukcia.org/research/DifferentialEffects/

Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts? (full - 2001)

http://www.cannabis-med.org/membersonly/mo.php?aid=2001-03-04&fid=2001-03-04-7&mode=p&sid=
226

The inheritance of chemical phenotype in Cannabis sativa L. (full - 2002)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462421/pdf/12586720.pdf

Cannabis / Marijuana ( Δ 9 -Tetrahydrocannabinol, THC) (full - 2002)

http://www.nhtsa.dot.gov/people/injury/research/job185drugs/cannabis.htm

Biochemical differences in Cannabis sativa L. depending on sexual phenotype (full - 2002) http://jag.igr.poznan.pl/2002-Volume-43/4/pdf/2002_Volume_43_4-451-462.pdf

Chemotaxonomic features associated with flavonoids of cannabinoid-free cannabis (Cannabis sativa subsp. sativa L.) in relation to hops (Humulus lupulus L.).
(abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/11942684

Composition of the essential oils and extracts of two populations of Cannabis sativa L. ssp. spontanea from Austria (full - 2003) http://findarticles.com/p/articles/mi_qa4091/is_/ai_n9299539

Cannabis: A source of useful pharma compounds neglected in India (news - 2003)

http://www.medpot.net/forums/index.php?showtopic=18608

A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae) (full - 2004) http://www.amjbot.org/cgi/content/full/91/6/966

The gene controlling marijuana psychoactivity: molecular cloning and heterologous expression of Delta1-tetrahydrocannabinolic acid synthase from Cannabis sativa L. (full – 2004) http://www.jbc.org/content/279/38/39767.long

Comparative Proteomics of Cannabis sativa Plant Tissues (full - 2004)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2291677&tool=pmcentrez

(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only. (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/15588739

NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa (abst - 2004) http://www.ncbi.nlm.nih.gov/pubmed/15595449?ordinalpos=53&itool=EntrezSystem2.PEntrez.Pubmed.Pu bmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Hemp-seed and olive oils: their stability against oxidation and use in O/W emulsions. (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/16130045

Plant cannabinoids: a neglected pharmacological treasure trove (full - 2005)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1751232&tool=pmcentrez

Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L.
(abst - 2005) http://www.ncbi.nlm.nih.gov/pubmed/15688956?ordinalpos=50&itool=EntrezSystem2.PEntrez.Pubmed.Pu bmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
227

Cultivation of Cannabis sativa L. in northern Morocco. (abst – 2005)

http://www.ncbi.nlm.nih.gov/pubmed/21338017

Chemical constituents of marijuana: the complex mixture of natural cannabinoids. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/16199061

Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/16024552

Pharmacokinetics and cannabinoid action using oral cannabis extract (news - 2005)

http://www.pharma-lexicon.com/medicalnews.php?newsid=29638

Cannabis confusions (full - 2006)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1336775&tool=pmcentrez

Evaluation of herbal cannabis characteristics by medical users: a randomized trial
(full - 2006) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1654142&tool=pmcentrez

Alpha-linolenic acid content of commonly available nuts in Hangzhou. (abst – 2006)

http://www.ncbi.nlm.nih.gov/pubmed/16711652

DNA poly morphisms in the tetrahydrocannabinolic acid (THCA) synthase gene in "drug-type" and "fiber-type" Cannabis sativa L. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16143478

Analysis of Choline and Atropine in Hairy Root Cultures of Cannabis Sativa L. by Capillary Electrophoresis-electrospray Mass Spectrometry. (abst – 2006) http://medical-journals.healia.com/doc/16637019/Analysis-of-choline-and-atropine-in-hairy-root-cultures- of-Cannabis-sativa-L.-by-capillary-electrophoresis-electrospray-mass-spectrometry

Identification and Characterization of Cannabinoids That Induce Cell Death through Mitochondrial Permeability Transition in Cannabis Leaf Cells (full – 2007) http://www.jbc.org/content/282/28/20739.full?sid=a5db98db-ff96-4187-8790-57097bbe15c1

Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis sativa. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17544411

Phytochemical and genetic analyses of ancient cannabis from Central Asia (full - 2008)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2639026&tool=pmcentrez

Characterization of Medicinal Properties of Cannabis sativa L. Roots (full - 2008)

http://archives.hempembassy.net/hempe/resources/blairvanpeltcannabisroot _NXPowerLite_.pdf

Non-cannabinoid constituents from a high potency Cannabis sativa variety. (abst - 2008)

http://www.unboundmedicine.com/medline/ebm/record/18774146/abstract/Non_cannabinoid_constituents_ from_a_high_potency_Cannabis_sativa_variety_
228

Cannabinoid Ester Constituents from High-Potency Cannabis sativa. (abst - 2008)

http://www.unboundmedicine.com/medline/ebm/record/18303850/abstract/Cannabinoid_Ester_Constituent s_from_High_Potency_Cannabis_sativa_

Identification of candidate genes affecting Δ9-tetrahydrocannabinol biosynthesis in Cannabis sativa (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736886/?tool=pmcentrez

2.0 Clinical Pharmacology (full - 2009)

http://www.hc-sc.gc.ca/dhp-mps/marihuana/how-comment/medpract/infoprof/clinical-clinique-eng.php

Hydroxylation and Further Oxidation of Δ9-Tetrahydrocannabinol by Alkane-Degrading Bacteria (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786519/?tool=pmcentrez

US Patent Application 20090324797 - MODULATING PLANT OIL LEVELS (full – 2009) http://www.patentstorm.us/applications/20090324797/fulltext.html

Effects of Gibberellic Acid on Primary Terpenoids and Delta-Tetrahydrocannabinol in Cannabis sativa at Flowering Stage. ( abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19522814/abstract/Effects_of_Gibberellic_Acid_o n_Primary_Terpenoids_and_Delta_Tetrahydrocannabinol_in_Cannabis_sativa_at_Flowering_Stage_

A qualitative and quantitative HPTLC densitometry method for the analysis of cannabinoids in Cannabis sativa L. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19609880/abstract/A_qualitative_and_quantitative _HPTLC_densitometry_method_for_the_analysis_of_cannabinoids_in_Cannabis_sativa_L_

Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material

(abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19932642
Δ9-Tetrahydrocannabinol content in cannabis samples seized in Novi Sad during 2008

(full – 2010) http://www.shd.org.rs/JSCS/Vol75/No7/02_4595_4015.pdf
In silicio expression analysis of PKS genes isolated from Cannabis sativa L. (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036156/?tool=pubmed

Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21040939

The Terpenes in the Cannabis Plant (news - 2010)

http://cannabination.com/2010/09/30/the-terpenes-in-the-cannabis-plant/

How Accurate is Potency Testing? (full – 2011)

http://www.canorml.org/RingTestOShaughnessys_Aut11.pdf

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21749363
229

Heterogeneity in the composition of marijuana seized in California. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21288662/abstract/Heterogeneity_in_the_composit ion_of_marijuana_seized_in_California_

Characteristics of cannabinoids composition of Cannabis plants grown in Northern Thailand and its forensic application. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21636228

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21798112

Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa). (abst -2011)

http://www.ncbi.nlm.nih.gov/pubmed/21902175

Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21938417

Cannabinoids: occurrence and medicinal chemistry. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21254969/abstract/Cannabinoids:_occurrence_and _medicinal_chemistry_

The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21244428/abstract/The_cannabinoid_type_1_recep tor_carboxyl_terminus_more_than_just_a_tail_

Cannabis profiling based on its elemental composition--is it possible? (abst – 2011)

http://marijuana.researchtoday.net/archive/8/9/4858.htm

The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis Potency and Yield. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22211717

A real-time PCR assay for the relative quantification of the tetrahydrocannabinolic acid (THCA) synthase gene in herbal Cannabis samples (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/22093702/abstract/A_real_time_PCR_assay_for_t he_relative_quantification_of_the_tetrahydrocannabinolic_acid__THCA__synthase_gene_in_herbal_Cann abis_samples_

Cannabis Sequencing Study Explores Differences Between Marijuana, Hemp Producing Plants (news – 2011)

http://www.genomeweb.com/sequencing/cannabis-sequencing-study-explores-differences-between- marijuana-hemp-producing

10 Questions To Ask Your Cannabis Scientist (news- 2011)

http://www.freedomisgreen.com/10-questions-to-ask-your-cannabis-scientist/

Chocolate & marijuana: chemical cousins (news – 2011)

http://www.examiner.com/drug-policy-in-reno/chocolate-marijuana-chemical-cousins
230
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 231 - 235

Proteomic profiling of hempseed proteins from Cheungsam. (abst - 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22040604

CHEMOTHERAPY

Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. (abst - 1975) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=4

Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. (abst - 1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=5

Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. (abst - 1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=23

Delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy; a double-blind cross-over trial against placebo (abst - 1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=27

Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9- tetrahydrocannabinol. (abst - 1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=107

Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. (abst - 1979) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=126

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. (abst - 1980) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=3

Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. (abst - 1980) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=6

The antiemetic activity of tetrahydrocanabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy. (abst - 1980) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=24

Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on

chemotherapy-induced emesis. (abst - 1980)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=131
231

Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications. (abst - 1981) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=88

Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting. (abst – 1981) http://www.ncbi.nlm.nih.gov/pubmed/7298877

Dose vs response of tetrahydroannabinol (THC) vs prochlorperazine as chemotherapy antiemetics. (abst - 1981) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=30

Comparative trial of the antiemetic effects of THC and haloperidol (abst - 1981)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=64

Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy. (abst – 1982) http://www.ncbi.nlm.nih.gov/pubmed/7139853

Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine. (abst – 1982) http://www.ncbi.nlm.nih.gov/pubmed/6284334

A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy. (abst - 1982) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=146

A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting. (abst - 1982) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=156

Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. (full - 1983) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011510/?tool=pmcentrez&page=1

Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy. (abst – 1983) http://www.ncbi.nlm.nih.gov/pubmed/6309451

Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting. (abst – 1985) http://www.ncbi.nlm.nih.gov/pubmed/2981616

THC or Compazine for the cancer chemotherapy patient--the UCLA study. Part II:

Patient drug preference. (abst - 1985)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=34
232

A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. (abst - 1985) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=128

Nabilone: an alternative antiemetic for cancer chemotherapy. (full - 1986)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1777777

Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy (abst - 1986) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=127

Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis. (abst - 1986) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=129

Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. (abst - 1987) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=120

Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy (abst - 1988) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=31

A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues. (abst – 1988) http://www.ncbi.nlm.nih.gov/pubmed/2838294

Peer Reviewed Results of New York State-sponsored Cancer/Marijuana Studies (abst - 1988) http://www.medmjscience.org/Pages/science/vinciguerra.html

Marijuana as antiemetic medicine : A Survey of Oncologists' Experiences and Attitudes (full - 1991) http://www.maps.org/docs/doblin-mt.html

Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy- induced nausea and vomiting. (abst - 1991) http://www.ncbi.nlm.nih.gov/pubmed/1652611

An efficient new cannabinoid antiemetic in pediatric oncology (full - 1995)

http://www.druglibrary.org/olsen/hemp/iha/iha02210.html

Therapeutic Aspects of Cannabis and Cannabinoids (full - 2001)

http://bjp.rcpsych.org/cgi/reprint/178/2/107.pdf

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative

systematic review (full - 2001)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC34325/?tool=pmcentrez
233

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review (full - 2001) http://findarticles.com/p/articles/mi_m0999/is_7303_323/ai_n27569247/?tag=content;col1

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review (abst - 2001) http://www.bmj.com/cgi/content/abstract/323/7303/16?ijkey=4c757e94f7e19cc6a3f945402c7dd6eb0fe3f04 e&keytype2=tf_ipsecsha

The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection. (abst - 2001) http://www.ncbi.nlm.nih.gov/pubmed/11854768?dopt=Abstract

Different views on the association between cannabinoids and cancer (abst - 2006)

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=16835997&dopt=abstrac tplus

Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases (abst - 2006) http://lib.bioinfo.pl/pmid:16408219

Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190028/?tool=pubmed

Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17566383

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. (abst - 2007) http://www.ncbi.nlm.nih.gov/pubmed/17355735?ordinalpos=7&itool=EntrezSystem2.PEntrez.Pubmed.Pub med_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Pot Compound May Offer ―Non-Toxic‖ Alternative To Chemotherapy (news – 2007)

http://www.norml.org/index.cfm?Group_ID=7433

Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin- Induced Cardiotoxicity (full - 2008) http://content.onlinejacc.org/cgi/content/full/50/6/528

Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain. (abst - 2008) http://www.ncbi.nlm.nih.gov/pubmed/18095921

Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review. (abst - 2009)

http://www.unboundmedicine.com/medline/ebm/record/19596652/abstract/Efficacy_of_Crude_Marijuana_ and_Synthetic_Delta_9_Tetrahydrocannabinol_as_Treatment_for_Chemotherapy_Induced_Nausea_and_V omiting:_A_Systematic_Literature_Review_
234

Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines. (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19394652

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. (full – 2010)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869084/?tool=pubmed

Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting (full – 2010) http://www.mdpi.com/1424-8247/3/9/2930/pdf

Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting (full - 2010) http://www.unboundmedicine.com/medline/ebm/record/21039759/abstract/Preliminary_efficacy_and_safet y_of_an_oromucosal_standardized_cannabis_extract_in_chemotherapy_induced_nausea_and_vomiting_

Regulation of nausea and vomiting by cannabinoids (abst - 2010)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476- 5381.2010.01176.x/abstract;jsessionid=56CED9CE51B025C161AA2E821BEC94ED.d01t01

Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682269/

Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice. (full – 2011) http://www.anesthesia-analgesia.org/content/113/4/947.long

Marijuana Extract Might Help Prevent Chemotherapy-Related Nerve Pain (news – 2011) http://www.newswise.com/articles/view/580864/?sc=rsmn

Cannabinoid 'Completely' Prevents Chemotherapy-Induced Neuropathy, Study Says (news – 2011) http://www.norml.org/index.cfm?Group_ID=8710

Marijuana component may ease pain from chemo therapy drugs (news – 2011)

http://www.jpost.com/Health/Article.aspx?id=241299

Ingredient in cannabis restores taste for cancer patients (news – 2011)

http://news.yahoo.com/s/afp/20110222/hl_afp/healthdiseasecancerdrugscannabisfood

Father: Medical marijuana eased pain of my cancer-battling son (anecdotal – 2011)

http://www.komonews.com/news/local/120941429.html
235
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 236 - 240

CHILDREN/ YOUNG ADULTS


Hemp Packs in Powerful Source of Preconception Nutrition (article - no date)

http://manitobaharvest.com/articles_studies/3812/Hemp-Packs-in-Powerful-Source-of-Preconception- Nutrition.html

HEMP AS A MEDICAMENT : Importance of hemp seeds in the tuberculosis therapy (Forum thread- full- 1955) (EDEZYME. recipe) http://www.greenpassion.org/showthread.php?p=306753#post306753

Survey of adolescent drug use. I. Sex and grade distribution. (full – 1971)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1530048/pdf/amjph00747-0113.pdf

Adolescent Marihuana Use: Role of Parents and Peers. (abst – 1976)

http://medical-journals.healia.com/doc/4726001/Adolescent-marihuana-use-role-of-parents-and-peers

Nabilone: an alternative antiemetic for cancer chemotherapy. (abst - 1986)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=123

Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children (abst - 1987) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=120

Marijuana Use in Pregnancy and Pregnancy Outcome. (abst – 1990)

https://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-999442

Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy. (abst – 1991) http://www.ncbi.nlm.nih.gov/pubmed/1957518

Prenatal marijuana use and neonatal outcome. (abst – 1991)

http://www.ncbi.nlm.nih.gov/pubmed/1886543

Analysis of Facial Shape in Children Gestationally Exposed to Marijuana, Alcohol, and/or Cocaine (abst - 1992) http://pediatrics.aappublications.org/cgi/content/abstract/89/1/67?maxtoshow=&hits=80&RESULTFORM AT=&fulltext=marihuana&searchid=1&FIRSTINDEX=960&resourcetype=HWCIT

60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. (abst – 1992) http://www.ncbi.nlm.nih.gov/pubmed/1469105

Prenatal Marijuana Exposure and Neonatal Outcomes in Jamaica: An Ethnographic Study (full - 1994) http://www.ukcia.org/research/can-babies.php

Prenatal exposure to marihuana and tobacco during infancy, early and middle childhood:

effects and an attempt at synthesis. (abst – 1995)

http://www.ncbi.nlm.nih.gov/pubmed/7786162
236

Prenatal tobacco and marijuana use among adolescents: effects on offspring gestational age, growth, and morphology. (abst – 1995) http://www.ncbi.nlm.nih.gov/pubmed/7724314

An efficient new cannabinoid antiemetic in pediatric oncology. (abst - 1995)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=7

The effectiveness of Drug Abuse Resistance Education (project DARE): 5-year follow-up results. (abst – 1996) http://www.ncbi.nlm.nih.gov/pubmed/8781009

Cannabis Cookies: a Cause of Coma. (abst – 1996)

http://www.ncbi.nlm.nih.gov/pubmed/9156535

Mortality Within the First 2 Years in Infants Exposed to Cocaine, Opiate, or Cannabinoid During Gestation (abst - 1997) http://pediatrics.aappublications.org/cgi/content/abstract/100/1/79?maxtoshow=&hits=80&RESULTFORM AT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=640&resourcetype=HWCIT

Maternal cannabis use and birth weight: a meta-analysis (abst – 1997)

http://www.ingentaconnect.com/content/carfax/cadd/1997/00000092/00000011/art00015

Dr. Melanie Dreher, reefer researcher (interview - 1998)

http://www.cannabisculture.com/v2/articles/1404.html

Cannabis and pregnancy (full - 1999)

http://www.ukcia.org/research/CannabisAndPregnancy.php

Ganja mothers, ganja babies (news - 1999)

http://www.cannabisculture.com/articles/1422.html

Marijuana and ADD- Therapeutic uses of Medical Marijuana in the treatment of ADD (news - 1999?) http://www.onlinepot.org/medical/add&mmj.htm

Cannabis use falls among Dutch youth (abst - 2000)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1118548/?tool=pubmed

Hemp Supplement Boosts Body AND Mind (anecdotal/news - 2001)

http://pr.cannazine.co.uk/201006011282/green/eco-news/hemp-supplement-boosts-body-and-mind.html

Maternal use of cannabis and pregnancy outcome. (abst – 2002)

http://www.ncbi.nlm.nih.gov/pubmed/11843371

Recipe For Trouble (news/anecdotal - 2002)

http://www.cbsnews.com/stories/2002/03/05/48hours/main503022.shtml

Comparison of meconium and neonatal hair analysis for detection of gestational exposure

to drugs of abuse (full - 2003)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1721515/pdf/v088p00F98.pdf
237

Experiences with THC-treatment in children and adolescents (abst - 2003)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=80

Effect of maternal under-nutrition on pup body weight and hypothalamic endocannabinoid levels. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12678501

Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. (full - 2005) http://ebm.rsmjournals.com/cgi/content/full/230/4/225

The cannabinoid system and its importance in the perinatal period (abst – 2005)

http://www.ncbi.nlm.nih.gov/pubmed/16266619

Treatment with CBD in oily solution of drug-resistant paediatric epilepsies. (abst - 2005)

http://www.cannabis- med.org/studies/ww_en_db_study_show.php?s_id=173&&search_pattern=EPILEPSY

Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor- mediated excitotoxic damage (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751782/?tool=pmcentrez

A preliminary DTI study showing no brain structural change associated with adolescent cannabis use (full - 2006) http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16684342

Effects of Alcohol and Combined Marijuana and Alcohol Use During Adolescence on Hippocampal Volume and Asymmetry (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821342/?tool=pubmed
Determination of the prevalence of drug misuse by meconium analysis

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672735/?tool=pubmed

The Mental Health Risks of Adolescent Cannabis Use (full - 2006)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1351917&tool=pmcentrez

(full - 2006)
Moderate cannabis use not harmful to the brain of adolescents, M R I study finds (news - 2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=218#3

Oily fish makes 'babies brainier' (news - 2006) (hemp seed- at the end)

http://news.bbc.co.uk/2/hi/health/4631006.stm

Cannabis is a First-Line Treatment for Childhood Mental Disorders (news - 2006)

http://www.counterpunch.org/mikuriya07082006.html

Dreher's Jamaican Pregnancy Study (news - 2006)

http://www.november.org/stayinfo/breaking06/DreherStudy.html

No 'Smoking' Gun: Research Indicates Teen Marijuana Use Does Not Predict Drug, Alcohol Abuse (news - 2006) http://www.sciencedaily.com/releases/2006/12/061204123422.htm
238

Pot May Not Shrink Teens' Brains After All (news - 2006)

http://www.medpagetoday.com/Neurology/GeneralNeurology/tb/3242

Some go without a cigarette: characteristics of cannabis users who have never smoked tobacco. (full - 2007) http://archpedi.ama-assn.org/cgi/content/full/161/11/1042

Illicit Drug Use in Young Adults and Subsequent Decline in General Health: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885466/?tool=pmcentrez

Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. (abst - 2007) http://www.ncbi.nlm.nih.gov/pubmed/17953730

Teens who use only cannabis appear to function better than those who also use tobacco (news - 2007) http://www.news-medical.net/news/2007/11/06/32262.aspx

Teens Who Smoke Marijuana But Not Tobacco Are Different From Other Teen Groups (news - 2007) http://www.sciencedaily.com/releases/2007/11/071105164453.htm

Swiss Study Finds Marijuana Use Alone May Benefit Some Teens (news - 2007)

http://www.foxnews.com/story/0,2933,308258,00.html

Are Cigarettes More of a Drag on Teens than Marijuana? (news - 2007)

http://www.scientificamerican.com/article.cfm?id=are-cigarettes-more-of-a

Breathe, Push, Puff? Pot Use and Pregnancy: A Review of the Literature (news – 2007)

http://norml.org/index.cfm?Group_ID=8060

Marijuana Use by Young People: The Impact of State Medical Marijuana Laws (full - 2008) http://www.mpp.org/assets/pdfs/general/TeenUseReport_0608.pdf

Volumetric MRI Study of Brain in Children With Intrauterine Exposure to Cocaine, Alcohol, Tobacco, and Marijuana (full - 2008) http://pediatrics.aappublications.org/cgi/reprint/121/4/741?maxtoshow=&hits=80&RESULTFORMAT=&f ulltext=marihuana&searchid=1&FIRSTINDEX=400&resourcetype=HWCIT

The association between anxiety and alcohol versus cannabis abuse disorders among adolescents in primary care settings (full - 2008) http://fampra.oxfordjournals.org/cgi/content/full/25/5/321

Characteristics of Adolescents Who Use Cannabis But Not Tobacco (news - 2008)

http://forum.grasscity.com/showthread.php?p=11734799#post11734799

Medical marijuana: a surprising solution to severe morning sickness (news - 2008)

http://current.com/items/89174292_medical-marijuana-a-surprising-solution-to-severe-morning- sickness.htm
239

When Your Kid Smokes Pot (news – 2008)

http://mensnewsdaily.com/2010/08/08/when-your-kid-smokes-pot/

Relief-oriented use of marijuana by teens (full - 2009)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2683812&tool=pmcentrez

Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring. (full - 2009) http://bjp.rcpsych.org/cgi/content/full/195/4/294

The influence of substance use on adolescent brain development. (full - 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827693/?tool=pubmed

Cannabis use and deliberate self-harm in adolescence: a comparative analysis of associations in England and Norway. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19813111/abstract/Cannabis_use_and_deliberate_s elf_harm_in_adolescence:_a_comparative_analysis_of_associations_in_England_and_Norway_

Cannabis use and destructive periodontal diseases among adolescents (abst - 2009)

http://www.unboundmedicine.com/medline/ebm/record/19236530/abstract/Cannabis_use_and_destructive_ periodontal_diseases_among_adolescents_

Urinary toxicological screening: Analytical interference between niflumic acid and cannabis. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19716686/abstract/[Urinary_toxicological_scre ening:_Analytical_interference_between_niflumic_acid_and_cannabis_%5D

Accidental cannabis poisoning in children: experience of the Marseille poison center (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19541448

Is moderate substance use associated with altered executive functioning in a population- based sample of young adults? (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19946940/full_citation/Is_moderate_substance_use _associated_with_altered_executive_functioning_in_a_population_based_sample_of_young_adults

Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. (abst – 2009) http://www.sciencedirect.com/science/article/pii/S0006899308030588

White Matter Integrity in Adolescents with Histories of Marijuana Use and Binge Drinking. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19631736/abstract/White_Matter_Integrity_in_Ad olescents_with_Histories_of_Marijuana_Use_and_Binge_Drinking_

Cannabis and tobacco use: where are the boundaries? A qualitative study on cannabis consumption modes among adolescents. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19515745/full_citation/Cannabis_and_tobacco_use :_where_are_the_boundaries_A_qualitative_study_on_cannabis_consumption_modes_among_adolescents _
240
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 241 - 245

Herbal Remedy: Teens Often Use Cannabis For Relief, Not Recreation, Study Finds (news - 2009) http://www.sciencedaily.com/releases/2009/04/090422191724.htm

Maternal Marijuana use not Associated with Psychotic Symptoms , but Alcohol is (news - 2009) http://ohiopatientsnetwork.org/index.php?option=com_content&view=article&id=85:marijuana-not- associated-with-psychotic-symptoms-but-alcohol-is&catid=3:newsflash

Why I Give My 9-year-old Pot (news/annecdotal - 2009)

http://www.doublex.com/section/health-science/why-i-give-my-9-year-old-pot

Why I Give My 9-Year-Old Pot, Part II (news/anecdotal - 2009)

http://www.doublex.com/section/health-science/why-i-give-my-9-year-old-pot-part-ii

Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861285/?tool=pubmed

The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed

Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects. (full – 2010) http://www.thefreelibrary.com/Learning+and+memory+performances+in+adolescent+users+of+alcohol+an d...-a0241277101

PTSD contributes to teen and young adult cannabis use disorders. (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784238/?tool=pubmed

Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients (abst - 2010) http://www.unboundmedicine.com/medline/ebm/record/19783382/abstract/Cannabis_withdrawal_severity_ and_short_term_course_among_cannabis_dependent_adolescent_and_young_adult_inpatients_

The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/21115947

Cannabis Use and Obesity and Young Adults ( abst - 2010)

http://informahealthcare.com/doi/abs/10.3109/00952990.2010.500438

A short-term, quasi-experimental evaluation of D.A.R.E.'s revised elementary school curriculum. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21038762

12 Year Olds More Likely to Use Potentially Deadly Inhalants Than Cigarettes or Marijuana (news - 2010) http://www.sciencedaily.com/releases/2010/03/100312144534.htm

'Marijuana is helping my 9-year-old (news/anecdotal - 2010)

http://theweek.com/article/index/202109/Marijuana_is_helping_my_9yearold
241

Why I Give My 9-Year-Old Pot, Part 3 (news - 2010) http://www.slate.com/id/2251174/ Teen Pot Smoking Won't Lead to Other Drugs as Adults (news - 2010)

http://www.webmd.com/parenting/news/20100902/teen-pot-smoking-wont-lead-to-other-drugs-as-adults

Marijuana May Offset Alcohol-Induced Cognitive Impairment Among Teens (news – 2010) http://www.norml.org/index.cfm?Group_ID=8378

Pregnant Women Smoking Pot Could Reduce Infant Mortality (news - 2010)

http://www.opposingviews.com/i/pregnant-women-smoking-pot-could-reduce-infant-mortality

Early exposure to Environmental enrichment alters the expression of genes of the endocannabinoid system (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21419109/abstract/Early_exposure_to_Environme ntal_enrichment_alters_the_expression_of_genes_of_the_endocannabinoid_system_

History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21890594

Some features of teenage beer alcoholism combined with hashish addiction (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21322145

The social contagion effect of marijuana use among adolescents. (full – 2011)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018468/?tool=pubmed

Gender differences in adolescent marijuana use and associated psychosocial characteristics. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21769049

Accidental cannabis poisoning in children: report of four cases in a tertiary care center from southern Spain (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21283933/abstract/[Accidental_cannabis_pois oning_in_children:_report_of_four_cases_in_a_tertiary_care_center_from_southern_Spain%5D_

Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20634020/abstract/Prolonged_coma_in_a_child_d ue_to_hashish_ingestion_with_quantitation_of_THC_metabolites_in_urine_

Pediatric cannabinoid hyperemesis: two cases. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21131803

Cannabinoids in children (abst – 2011)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295

Rural adolescent alcohol, tobacco, and illicit drug use: a comparison of students in

victoria, australia, and washington state, United States. (abst – 2011)

http://marijuana.researchtoday.net/archive/8/10/4782.htm
242

The association between early conduct problems and early marijuana use in college students. (abst – 2011) http://marijuana.researchtoday.net/archive/8/9/4850.htm

Father: Medical marijuana eased pain of my cancer-battling son (anecdotal – 2011)

http://www.komonews.com/news/local/120941429.html

The Kids Are All Right, Even if Their Parents Grow Pot (news – 2011)

http://www.parentdish.com/2011/07/27/the-kids-are-all-right-even-if-their-parents-grow-pot/

Legalizing Medical Marijuana Does Not Increase Use Among Youth, Study Suggests (news - 2011) http://www.sciencedaily.com/releases/2011/11/111102161047.htm

'Fake Marijuana' May Trigger Heart Trouble in Teens (news – 2011)

http://health.yahoo.net/news/s/hsn/fakemarijuanamaytriggerhearttroubleinteens

Are smart kids more likely to use drugs? (news – 2011)

http://news.yahoo.com/smart-kids-more-likely-drugs-160000571.html

Why I Give My Autistic Son Pot, Part 4 (news – 2011)

http://www.slate.com/id/2294072/?from=rss

High Childhood IQ Linked to Subsequent Illicit Drug Use, Research Suggests (news – 2011) http://www.sciencedaily.com/releases/2011/11/111114221018.htm

Study: Legal Medical Marijuana Doesn't Encourage Kids to Smoke More Pot (news – 2011) http://news.gather.com/viewArticle.action?articleId=281474980744307

CHOLERA

Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice.
(abst – 1999) http://www.ncbi.nlm.nih.gov/pubmed/10218903

An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12949722

Marijuana for cholera therapy (letter – 2005)

https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(05)00266-X
243

CHOLESTEROL


Cannabinoids impair the formation of cholesteryl ester in cultured human cells. (full – 1981) http://atvb.ahajournals.org/cgi/reprint/1/6/449

Cholesterol-induced stimulation of platelet aggregation is prevented by a hempseed- enriched diet. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18418423

Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug (news – 2009) http://www.thefreelibrary.com/Cannabis+plant+extracts+could+potentially+form+the+basic+ingredients...- a0202701009

The Non-Psychoactive Plant Cannabinoid, Cannabidiol Affects Cholesterol Metabolism- Related Genes in Microglial Cells. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21533611

The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21331775

The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21893466

CHRONIC FATIGUE SYNDRONE

A Practical treatise on nervous exhaustion (neurasthenia) aka Chronic Fatigue Syndrome (full – 1894) http://www.scribd.com/doc/49652565/Chronic-Fatigue-Syndrome-Cannabis-Treatment-1894

COGNATIVE EFFECTS- see IQ

COLITIS

Ulcerative Colitis and Marijuana (letter - 1990)

http://www.druglibrary.org/schaffer/hemp/medical/colitis1.htm

Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of

mustard and by dextran sulfate sodium. (full – 2006)

http://ajpgi.physiology.org/content/291/2/G364.long
244

Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide. (full – 2008) http://www.jpp.krakow.pl/journal/archive/12_08/pdf/673_12_08_article.pdf

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18493729

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. (full - 2009) http://onlinelibrary.wiley.com/doi/10.1002/ibd.20960/full

Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731878/?tool=pmcentrez

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19690824/abstract/Cannabidiol_a_safe_and_non_p sychotropic_ingredient_of_the_marijuana_plant_Cannabis_sativa_is_protective_in_a_murine_model_of_c olitis_

Cannabis for Ulcerative Colitis and Crohn's Disease treatment (news - 2009)

http://www.news-medical.net/news/20091217/Cannabis-for-Ulcerative-Colitis-and-Crohns-Disease- treatment.aspx

The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn's Disease (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829088/?tool=pmcentrez

Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis. (full – 2010) http://www.jpp.krakow.pl/journal/archive/02_10/pdf/89_02_10_article.pdf

The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21080464

Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232190/?tool=pubmed

Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21551239/abstract/Increasing_endogenous_2_arac hidonoylglycerol_levels_counteracts_colitis_and_related_systemic_inflammation_
245
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 246 - 250

β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21356367

Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21876860

Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22119709

COPD/ CHRONIC OBSTRUCTIVE PUMONARY DISEASE

Heavy Habitual Marijuana Smoking Does Not Cause an Accelerated Decline in FEV with Age (full - 1997) http://www.drugtext.org/library/research/cannabis/respiration/respiration02/resp02.htm

Marijuana. Respiratory tract effects. (abst - 1997)

http://www.ncbi.nlm.nih.gov/pubmed/9358987

Heavy Long-Term Marijuana Use Does Not Impair Lung Function (news - 1997)

http://www.erowid.org/plants/cannabis/cannabis_media7.shtml

The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues. (full – 2005) http://www.jstage.jst.go.jp/article/jphs/98/1/77/_pdf

THC effective in appetite and weight loss in severe lung disease (COPD) (news - 2005)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=191#2

Researchers to test if cannabis ingredient can help COPD patients (news - 2005)

http://www.thehempire.com/index.php/cannabis/news/researchers_to_test_if_cannabis_ingredient_can_hel p_copd_patients

Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720277/?tool=pmcentrez

No Decrease in Pulmonary Function Associated with Long-Term Cannabis Smoking, Study Says (news - 2007) http://www.illinoisnorml.org/content/view/366/27/

Marijuana and chronic obstructive lung disease: a population-based study (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665947/?tool=pmcentrez
246

US Patent Application 20090197941 - Pharmaceutical Compositons for the Treatment of Chronic Obstructive Pulmonary Disease (full – 2009) http://www.patentstorm.us/applications/20090197941/fulltext.html

Does smoking marijuana increase the risk of chronic obstructive pulmonary disease? (article - 2009) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2665954&tool=pmcentrez
Smoking Pot, Cigarettes Ups COPD Risk (news - 2009)

http://www.webmd.com/news/20090413/smoking-pot-cigarettes-ups-copd-risk

Effects of cannabis on lung function: a population-based cohort study.

http://erj.ersjournals.com/content/35/1/42.long

Effects of smoking cannabis on lung function (full – 2011)

http://www.expert-reviews.com/doi/full/10.1586/ers.11.40

(full - 2010)
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety (abst – 2011) http://crd.sagepub.com/content/early/2011/01/23/1479972310391283.abstract

Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21056512

Marijuana Smoke Not as Damaging as Tobacco, Says Study (news - 2012)

http://news.yahoo.com/marijuana-smoke-not-damaging-tobacco-says-study-204709671--abc-news.html

COUGH

Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea- pigs by cannabinoid (CB2) receptor activation. (full - 2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574031/?tool=pubmed

Patent 6974568 - Treatment for cough (full - 2005)

http://www.patentstorm.us/patents/6974568/fulltext.html

Effect of N-arachidonoyl-(2-methyl-4-hydroxyphenyl) amine (VDM11), an anandamide transporter inhibitor, on capsaicin-induced cough in mice (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448189/?tool=pmcentrez

Novel treatment for cough (full - 2006)

http://appft1.uspto.gov/netacgi/nph- Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1& f=G&l=50&s1=%2220060013777%22.PGNR.&OS=DN/20060013777&RS=DN/20060013777
247

Cannabis Cough Cure (news - 2006)

http://www.thehempire.com/index.php/cannabis/news/cannabis_cough_cure

G-protein coupled receptors regulating cough. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21727026

COWPOX

"Recreational" drug abuse associated with failure to mount a proper antibody response after a generalised orthopoxvirus infection. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/17917699

CP 47,497 - a synthetic cannabinoid, CB1 & CB2 agonist

Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol
(abst - 1982) http://jpet.aspetjournals.org/content/223/2/516.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=Hexahydrocannabinol&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940 (full - 1996) http://www.jbc.org/content/271/18/10640.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=Hex ahydrocannabinol&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus (abst – 2005) http://www.sciencedirect.com/science/article/pii/S0028390805001668

Withdrawal Phenomena and Dependence Syndrome After the Consumption of "Spice Gold" (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719097/?tool=pmcentrez

Spice drugs: cannabinoids as a new designer drugs. (abst - 2009)

http://www.unboundmedicine.com/medline/ebm/record/19718488/abstract/[Spice_drugs:_cannabinoid s_as_a_new_designer_drugs_%5D

Spice: a never ending story? (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19589652

Pharmacological properties and dependence liabilities of synthetic cannabinoids
(abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20681249/abstract/[Pharmacological_propertie s_and_dependence_liabilities_of_synthetic_cannabinoids%5D_
248

Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20857386

THIS ISN'T YOUR MOTHER'S SPICE (news - 2010)

http://www.mapinc.org/drugnews/v10/n497/a07.html?1173

Now, There's a Test for That -- Norchem's "Fake Marijuana" Test Reveals Significantly Increased Abuse of Spice/K2 (news - 2010) http://www.marketwire.com/press-release/Now-Theres-Test-That-Norchems-Fake-Marijuana-Test- Reveals-Significantly-Increased-Abuse-1356247.htm

College students and use of K2: an emerging drug of abuse in young persons (full – 2011) http://www.substanceabusepolicy.com/content/6/1/16

Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse? (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139381/?tool=pubmed

Beyond THC: The New Generation of Cannabinoid Designer Drugs. (full – 2011)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187647/?tool=pubmed
Investigating a not-so-natural high. (full – 2011) http://pubs.acs.org/doi/full/10.1021/ac900564u

CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21333643

A method for CP 47, 497 a synthetic non-traditional cannabinoid in human urine using liquid chromatography tandem mass spectrometry. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21233028

Synthetic cannabinoids in oral fluid. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21871150

Cytotoxicity of synthetic cannabinoids found in "Spice" products: The role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21907772

Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20529459

Effects of synthetic cannabinoids on electroencephalogram power spectra in rats.
(abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabino ids_on_electroencephalogram_power_spectra_in_rats_

The emergence and analysis of synthetic cannabinoids. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21337724
249

Chemicals Used in "Spice" and "K2" Type Products Now Under Federal Control and Regulation (news – 2011) http://www.justice.gov/dea/pubs/pressrel/pr030111.html

CP 50,556-1 / LEVONANTRADOL synthetic, CB1 & CB2 agonist

Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting. (abst – 1981) http://www.ncbi.nlm.nih.gov/pubmed/7298877

Randomised Clinical Trial of Levonantradol and Chlorpromazine in the Prevention of Radiotherapy-induced Vomiting. (abst - 1982) http://www.ncbi.nlm.nih.gov/pubmed/6754212

Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy. (abst – 1982) http://www.ncbi.nlm.nih.gov/pubmed/7139853

Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and delta 9-tetrahydrocannabinol in anesthetized cats. (abst - 1983) http://jpet.aspetjournals.org/content/227/2/508.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=marihuana&searchid=1&FIRSTINDEX=1920&resourcetype=HWCIT

Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy. (abst – 1983) http://www.ncbi.nlm.nih.gov/pubmed/6309451

Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting. (abst – 1985) http://www.ncbi.nlm.nih.gov/pubmed/2981616

Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses. (abst – 1999) http://www.ncbi.nlm.nih.gov/pubmed/10080239

Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A. (full – 2001) http://www.nature.com/npp/journal/v24/n2/full/1395605a.html

Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse? (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139381/?tool=pubmed
250
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 251 - 255

CP 55,940
- a synthetic cannabinoid-CB1 & CB2 agonist
Molecular cloning of a human cannabinoid receptor which is also expressed in testis

(abst – 1991) http://pharmgkb.org/pmid/1718258

Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. (full - 1992) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907498/?tool=pmcentrez&page=1

Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. (full - 1993) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175863/?tool=pmcentrez&page=1

Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord (full - 1997) http://jpet.aspetjournals.org/content/281/2/730.full

Cannabinoid Receptor Agonists Protect Cultured Rat Hippocampal Neurons from Excitotoxicity (full - 1998) http://molpharm.aspetjournals.org/content/54/3/459.full

Potent Effects of a Selective Cannabinoid Receptor Agonist on Some Guinea Pig Medial Vestibular Nucleus Neurons. (abst – 1998) http://medical-journals.healia.com/doc/9650841/Potent-effects-of-a-selective-cannabinoid-receptor- agonist-on-some-guinea-pig-medial-vestibular-nucleus-neurons

The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats (abst - 1999) http://www.ncbi.nlm.nih.gov/pubmed/10611417

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human (full - 2000)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1571997/?tool=pmcentrez

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation (full - 2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572987/?tool=pmcentrez

Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. (abst - 2001) http://www.ncbi.nlm.nih.gov/pubmed/11566149

The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. (full – 2002) http://jpet.aspetjournals.org/content/300/1/34.long

Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl

Glycerol, in Rat Brain (full - 2003)

http://www.nature.com/npp/journal/v28/n6/full/1300117a.html
251

Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea- pigs by cannabinoid (CB2) receptor activation. (full - 2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574031/?tool=pubmed

CANNABINOIDS ALTER RECOGNITION MEMORY IN RATS (full – 2003)

http://www.if-pan.krakow.pl/pjp/pdf/2003/5_903.pdf

Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central Amygdala (full - 2005) http://www.nature.com/npp/journal/v30/n3/full/1300535a.html

Avoidance of Abeta[(25-35)] / (H(2)O(2)) -induced apoptosis in lymphocytes by the cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and PI3K- dependent mechanisms: role of NF-kappaB and p53. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/17017986

Endocannabinoids -- The Brain's Cannabis -- Demonstrate Novel Modes Of Action To Stress (news - 2005) http://www.sciencedaily.com/releases/2005/07/050720065810.htm

Chronologically overlapping occurrences of nicotine-induced anxiety- and depression- related behavioral symptoms: effects of anxiolytic and cannabinoid drugs (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075518/?tool=pubmed

Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors. (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189718/?tool=pubmed

Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. (full - 2007) http://journals.lww.com/anesthesiology/pages/articleviewer.aspx?year=2007&issue=04000&article=00021 &type=abstract

CB2 receptors in the brain: role in central immune function (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219530/?tool=pmcentrez

Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells (full - 2008) http://molpharm.aspetjournals.org/content/74/1/20.full?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block

Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells (full - 2008) http://www.jimmunol.org/cgi/content/full/181/9/6406?maxtoshow=&hits=80&RESULTFORMAT=&fullte xt=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT

The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease. (abst - 2008) http://www.ncbi.nlm.nih.gov/pubmed/18538428
252

Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19237169

Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813317/?tool=pubmed

Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846023/?tool=pubmed

Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. (abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20375197/abstract/Rimonabant_induced_Delta9_te trahydrocannabinol_withdrawal_in_rhesus_monkeys:_discriminative_stimulus_effects_and_other_withdra wal_signs_

Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20514518

Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21029743

Cytotoxicity of synthetic cannabinoids found in "Spice" products: The role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21907772

Chronic Δ9-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21091643/abstract/Chronic_%CE%94%E2%81%B 9_tetrahydrocannabinol_treatment_in_rhesus_monkeys:_differential_tolerance_and_cross_tolerance_amon g_cannabinoids_

The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20701826/abstract/The_schizophrenia_susceptibilit y_gene_neuregulin_1_modulates_tolerance_to_the_effects_of_cannabinoids_

A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21492165/abstract/A_synthetic_cannabinoid_CP55 940_inhibits_lipopolysaccharide_induced_cytokine_mRNA_expression_in_a_cannabinoid_receptor_indep endent_mechanism_in_rat_cerebellar_granule_cells_
253

CROHN'S
- see BOWEL DISODERS

CRUETZFELDT-JACOB DISEASE - see MAD COW DISEASE

CT-3 - synthetic –also see AJULMIC ACID

Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. (full - 2003)
http://jama.ama- assn.org/cgi/content/full/290/13/1757?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&se archid=1&FIRSTINDEX=0&resourcetype=HWCIT

Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances. (abst - 2007) http://www.ncbi.nlm.nih.gov/pubmed/17868014

CYSTIC FIBROSIS

I have Cystic fibrosis (anecdotal - no date)

http://www.masscann.org/consumption/73-medicine/314-i-have-cystic-fibrosis

The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. (abst - 2004) http://www.ncbi.nlm.nih.gov/pubmed/15159678

Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15910887

Vaporized marijuana effect on CF. NOT smoking (forum post - 2007)

http://www.topix.com/forum/health/cystic-fibrosis/TBQ56B1VNGGAODTKA

Marijuana (Cannabis) and Cystic Fibrosis; A Case Study (case study/ad- 2009)

http://mcsocal.com/blog/marijuana-cannabis-and-cystic-fibrosis-a-case-study/
(abst – 1987) Cannabinoids and cystic fibrosis: a novel approach to etiology and therapy. (full - 2002)

Recreational use of psychoactive drugs by patients with cystic fibrosis.

http://www.ncbi.nlm.nih.gov/pubmed/3497251 http://www.cannabis-med.org/data/pdf/2002-01-2.pdf
254

"Bong lung" in cystic fibrosis: a case report (full - 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998526/?tool=pmcentrez

CYSTITIS

Cannabinoid rotation in a young woman with chronic cystitis (abst - 2003)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=115

Marijuana-Derived Drug Suppresses Bladder Overactivity And Irritation In Animal Models (news - 2005) http://www.sciencedaily.com/releases/2005/09/050906080225.htm

Marijuana-Derived Drug Promises Hope In Treating Bladder Infection (news – 2005)

http://www.bio-medicine.org/medicine-news/Marijuana-Derived-Drug-Promises-Hope-In-Treating- Bladder-Infection-4724-1/

Marijuana-Derived Drug Suppresses Bladder Pain In Animal Models (news - 2006)

http://www.sciencedaily.com/releases/2006/05/060521103039.htm

DENTISTRY - see TEETH

DEPRESSION

The perceived effects of smoked cannabis on patients with multiple sclerosis. (abst - 1997) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=13

Anxiety with Depression Research Review (full - 2000)

http://www.ukcia.org/research/AnxietyWithDepressionResearchReview.pdf

Therapeutic Aspects of Cannabis and Cannabinoids (full - 2001)

http://bjp.rcpsych.org/cgi/reprint/178/2/107.pdf

Association between cannabis use and depression may not be causal, study says (news - 2004) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=177#4

Cannabinoids promote hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects (full - 2005) http://www.jci.org/cgi/content/full/115/11/3104
255
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 256 - 260

Antidepressant-like activity by blockade of anandamide hydrolysis
(full - 2005) http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16352709

Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) (full - 2005) http://www.nature.com/tpj/journal/v5/n2/full/6500301a.html

Antidepressant-like Activity and Modulation of Brain Monoaminergic Transmission by Blockade of Anandamide Hydrolysis. (full – 2005) http://www.pnas.org/content/102/51/18620.long

New Antidepressant Drug Increases 'Brain's Own Cannabis' (news - 2005)

http://www.sciencedaily.com/releases/2005/12/051213172852.htm

Cannabis' Acts as Antidepressant (news - 2005)

http://www.thehempire.com/index.php/cannabis/news/cannabis_acts_as_antidepressant

Cannabis And Depression Research (news - 2005)

http://www.thehempire.com/index.php/cannabis/news/cannabis_and_depression_research

High-dose cannabis stimulates growth of brain cells in rats (news – 2005)

http://www.independent.co.uk/life-style/health-and-families/health-news/highdose-cannabis-stimulates- growth-of-brain-cells-in-rats-510869.html

Good News For The Medical Marijuana Movement: Pot Proliferates Brain Cells And Boosts Mood (news - 2005) http://www.sciencedaily.com/releases/2005/10/051014073523.htm

Marijuana might cause new cell growth in the brain (news – 2005)

http://www.newscientist.com/article/dn8155

Surprising Brain Effects From Pot-Like Drug (news – 2005)

http://www.webmd.com/mental-health/news/20051013/surprising-brain-effects-from-pot-like-drug

Decreased depression in marijuana users. (full - 2006)

http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/DecreasedDepressionInMjUsers05.pdf

The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients (abst - 2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=177

Marijuana use and depression among adults: Testing for causal associations.
(abst - 2006) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=1696834 8&ordinalpos=412&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Do patients use marijuana as an antidepressant? (abst - 2006)

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=9160645 &ordinalpos=32&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
256

A possible role for the endocannabinoid system in the neurobiology of depression (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169225/?tool=pubmed

Chronologically overlapping occurrences of nicotine-induced anxiety- and depression- related behavioral symptoms: effects of anxiolytic and cannabinoid drugs (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075518/?tool=pubmed

Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. (full - 2007) http://www.jneurosci.org/cgi/content/full/27/43/11700

Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17511970

Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep. (abst - 2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=190

Marijuana-Like Brain Chemicals Work As Antidepressant (news - 2007)

http://www.sciencedaily.com/releases/2007/11/071105120556.htm

Marijuana chemical may treat depression (news - 2007)

http://www.healthcentral.com/depression/news-268391-98.html

Cannabis: Potent Anti-Depressant In Low Doses, Worsens Depression At High Doses (news - 2007) http://www.sciencedaily.com/releases/2007/10/071023183937.htm

Synthetic form of THC is an effective anti-depressant at low doses (news - 2007)

http://www.news-medical.net/news/2007/10/24/31666.aspx?page=2

Treating depression with cannabinoids (full - 2008)

http://www.cannabis-med.org/english/journal/en_2008_02_2.pdf

Animal research highlights a therapeutic potential of cannabinoids for the treatment of depression (full - 2008) http://www.cannabis-med.org/english/journal/en_2008_02_1.pdf

Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/20590564

Cannabis and suicide: longitudinal study. (abst - 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19949196

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/?tool=pubmed

Brain CB2 Receptors: Implications for Neuropsychiatric Disorders (full – 2010)

http://www.mdpi.com/1424-8247/3/8/2517/pdf
257

Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861285/?tool=pubmed

Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20692131

Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress (abst - 2010) http://www.nature.com/npp/journal/vaop/ncurrent/abs/npp201099a.html

Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? (abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20512266/abstract/[Pharmacological_exploitat ion_of_the_endocannabinoid_system:_new_perspectives_for_the_treatment_of_depression_and_anxiety_d isorders%5D_

Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. (abst – 2011) http://www.nature.com/neuro/journal/v14/n3/full/nn.2736.html

Endocannabinoid system dysfunction in mood and related disorders. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21916860

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21238581

Cannabinoids and emotionality: a neuroanatomical perspective. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21827834

Deficiency of Dietary Omega-3 May Explain Depressive Behaviors (news - 2011)

http://www.thefreelibrary.com/Deficiency+of+Dietary+Omega-3+May+Explain+Depressive+Behaviors.- a0248155576

Omega-3 PUFA Deficiency Abolishes Endocannabinoid-Linked Neuronal Functions (news - 2011) http://www.fatsoflife.com/article.php?nid=1&edition=this&id=1837&issueid=85

Scientific research reveals brain alterations linking omega 3 deficit with depression (news – 2011) http://www.physorg.com /news/2011-02-scientific-reveals-brain-linking-omega.html

A deficiency of dietary omega-3 may explain depressive behaviors (news - 2011)

http://www.physorg.com/news/2011-01-deficiency-dietary-omega-depressive-behaviors.html

A Brain Wrought Without Omega-3 (news – 2011)

http://www.schizophreniaforum.org/new/detail.asp?id=1646

Omega-3 deficiency disrupts cannibinoid receptor function in brain (news – 2011)

http://www.wellsphere.com/general-medicine-article/omega-3-deficiency-disrupts-cannibinoid-receptor- function-in-brain/1347465
258

DERMATITIS


Allergenic properties of naturally occurring cannabinoids. (abst - 1983)

http://www.ncbi.nlm.nih.gov/pubmed/6620158

Hemp Seed Oil : The Wonder Oil For the New Millennium (full - 1999)

http://www.ukcia.org/research/Happi/HempSeedOilTheWonderOilForTheNewMillennium.htm

The Endocannabinoid System in Human Keratinocytes (full – 2003)

http://www.jbc.org/content/278/36/33896.full

Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12835895

Hemp-seed and olive oils: their stability against oxidation and use in O/W emulsions. (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/16130045

Efficacy of dietary hempseed oil in patients with atopic dermatitis. (abst - 2005)

http://www.ncbi.nlm.nih.gov/pubmed/16019622

Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2- Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice (full – 2006) http://www.jimmunol.org/content/177/12/8796.full

Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner (full – 2007) http://www.jbc.org/content/283/10/6005.full?sid=931583b1-e797-43e0-8296-7fd75bb49403#sec-4

Want Nice Skin? Then Smoke Cannabis! (news – 2007)

http://news.softpedia.com/news/Want-Nice-Skin-Then-Smoke-Cannabis-56803.shtml

Role seen for cannabis in helping to alleviate allergic skin disease (news - 2007)

http://www.physorg.com/news106487623.html

Allergic Skin Disease Could Be Treated With Substance Found In Cannabis (news – 2007) http://www.medicalnewstoday.com/releases/79889.php

Hashing Out Allergic Contact Dermatitis — Another Medical Use for Marijuana?
(news - 2007) http://dermatology.jwatch.org/cgi/content/full/2007/622/1?maxtoshow=&hits=80&RESULTFORMAT=&f ulltext=cannabinoid&searchid=1&FIRSTINDEX=1920&resourcetype=HWCIT

Cannabis May Help Alleviate Allergic Skin Disease (news - 2007)

http://www.sciencedaily.com/releases/2007/08/070816094649.htm
259

Constituents Of Hashish And Marijuana May Help To Fight Inflammation And Allergies (news - 2007) http://www.sciencedaily.com/releases/2007/06/070607171120.htm

Cannabis compound reduces skin allergies in mice (news – 2007)

http://www.newscientist.com/article/dn12016-cannabis-compound-reduces-skin-allergies-in-mice.html

Marijuana Might Help Cure Allergic Contact Dermatitis (a.k.a. Poison Ivy) (news - 2007) http://www.healthcentral.com/skin-cancer/c/83/12569/cure-aka-ivy/1/

Marijuana Skin Cream? (news - 2007)

http://www.drugfree.org/join-together/drugs/marijuana-skin-cream

Cannabis for allergic contact dermatitis (news - 2007)

http://www.news-medical.net/news/2007/08/17/28901.aspx

Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System
(full - 2008)
http://pediatrics.aappublications.org/cgi/reprint/122/Supplement_4/S200- a?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=1120 &resourcetype=HWCIT

Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. (full – 2008) http://www.fasebj.org/content/22/10/3685.long

Body's Own 'Cannabis (Marijuana)' Is Good For The Skin, Scientists Find (news - 2008) http://www.sciencedaily.com/releases/2008/07/080702160944.htm

Substances Similar To The Body's Own 'Cannabis (Marijuana) Are Necessary For Healthy Skin And May Lead To New Skin Disease Treatments (news - 2008) http://www.medicalnewstoday.com/articles/113812.php

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/?tool=pmcentrez

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis (full - 2009) http://www3.interscience.wiley.com/cgi-bin/fulltext/122290593/HTMLSTART

Cannabinoid system in the skin - a possible target for future therapies in dermatology. (full - 2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0625.2009.00923.x/full

Granny's cannabis skin ointment really did work, new study shows (news - 2009)

http://current.com/items/89838741_grannys-cannabis-skin-ointment-really-did-work-new-study-shows.htm

Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20206138
260
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 261 - 265

Protective role of palmitoylethanolamide in contact allergic dermatitis. (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/19909294

Hemp Seed Oil for Skin (news – 2010)

http://www.livestrong.com/article/340189-hemp-seed-oil-for-skin/

Endocannabinoid signaling and epidermal differentiation.

http://www.ncbi.nlm.nih.gov/pubmed/21628127

DEXANABINOL - see HU-211

DIABETES

(abst – 2011)
Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes (abst - 2004) http://abstracts.iovs.org/cgi/content/abstract/45/5/860?maxtoshow=&hits=80&RESULTFORMAT=&fullte xt=cannabinoid&searchid=1&FIRSTINDEX=1760&resourcetype=HWCIT

The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats. (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/15519750

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice (full - 2005)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270485/?tool=pmcentrez

Activation of the Peripheral Endocannabinoid System in Human Obesity (full - 2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228268/?tool=pmcentrez

Gpr40 Gene Expression in Human Pancreas and Insulinoma. (abst – 2005)

http://medical-journals.healia.com/doc/16289108/GPR40-gene-expression-in-human-pancreas-and- insulinoma

The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse. (abst – 2005) http://medical-journals.healia.com/doc/16054069/The-FFA-receptor-GPR40-links-hyperinsulinemia- hepatic-steatosis-and-impaired-glucose-homeostasis-in-mouse

Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in

Experimental Diabetes (full - 2006)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592672/?tool=pubmed
261

Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia (full - 2006) http://jcem.endojournals.org/cgi/content/full/91/8/3171?ijkey=83a68cef202eafe129332eda53eee8eb613499 82

Weight Control in Individuals With Diabetes (full - 2006)

http://care.diabetesjournals.org/content/29/12/2749.full?maxtoshow=&hits=80&RESULTFORMAT=&full text=cannabis&searchid=1&FIRSTINDEX=2000&resourcetype=HWCIT

Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/17011761

Expression of the Gene for a Membrane-bound Fatty Acid Receptor in the Pancreas and Islet Cell Tumours in Humans: Evidence for Gpr40 Expression in Pancreatic Beta Cells and Implications for Insulin Secretion. (abst – 2006)

http://medical-journals.healia.com/doc/16525841/Expression-of-the-gene-for-a-membrane-bound-fatty- acid-receptor-in-the-pancreas-and-islet-cell-tumours-in-humans-evidence-for-GPR40-expression-in- pancreatic-beta-cells-and-implications-for-insulin-secretion

The Cannabinergic System as a Target for Anti-inflammatory Therapies
(abst - 2006) http://www.ingentaconnect.com/content/ben/ctmc/2006/00000006/00000013/art00008

Non-Psychoactive Cannabinoid Reduces Incidence Of Diabetes, Study Says (news - 2006) http://www.norml.org/index.cfm?Group_ID=6909

Marijuana Compound May Help Stop Diabetic Retinopathy (news - 2006)

http://www.sciencedaily.com/releases/2006/02/060227184647.htm

Cannabidiol, a marijuana compound, may help stop diabetic retinopathy (news – 2006)

http://www.xagena.it/news/medicinenews_net_news/549d841c3704e2b6a273a258dd0b6f17.html

Marijuana Compound Offers Hope In Diabetic Retinopathy Prevention (news – 2006)

http://www.bio-medicine.org/medicine-news/Marijuana-Compound-Offers-Hope-In-Diabetic-Retinopathy- Prevention-8121-1/

Cannabidiol reduces the development of diabetes in an animal study (news - 2006)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=219#3

Getting Eye On Cannabinoids (news - 2006)

http://www.thehempire.com/index.php/cannabis/news/getting_eye_on_cannabinoids

Marijuana compound could prevent eye damage in diabetics (news - 2006)

http://www.thehempire.com/index.php/cannabis/news/marijuana_compound_could_prevent_eye_damage_i n_diabetics

Cannabidiol arrests onset of autoimmune diabetes in NOD mice (full - 2007)

http://safeaccess.ca/research/pdf/WeissCBD_ArrestsDiabetesNeuropharmacology2007.pdf
262

Expression of Cannabinoid CB1 Receptors in Models of Diabetic Neuropathy
(full - 2007) http://jpet.aspetjournals.org/content/323/2/508.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext= cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT

Cannabidiol attenuates high-induced endothelial cell inflammatory response and barrier disruption (full - 2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2228254&tool=pmcentrez

US Patent Application 20070099987 - Treating or preventing diabetes with cannabidiol (full – 2007) http://www.patentstorm.us/applications/20070099987/fulltext.html

Role of cannabinoid CB2 receptors in glucose homeostasis in rats (abst – 2007)

http://www.sciencedirect.com/science/article/pii/S001429990700249X

The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells (abst - 2007) http://lib.bioinfo.pl/pmid:17604177

Anticoagulant Effects of a Cannabis Extract in an Obese Rat Model (abst - 2007)

http://marijuana.researchtoday.net/archive/4/4/736.htm

Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588644/?tool=pmcentrez

The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids (full – 2008) http://diabetes.diabetesjournals.org/content/57/5/1262.full?sid=00769f3d-54ab-451b-b69e-4650931c5e25

GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268073/?tool=pmcentrez

Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full - 2008) http://www.nature.com/oby/journal/v16/n3/full/oby2007106a.html

Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592995/?tool=pubmed

Endocannabinoids and the Control of Energy Homeostasis (full – 2008)

http://www.jbc.org/content/283/48/33021.full?sid=931583b1-e797-43e0-8296-7fd75bb49403

Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full – 2008) http://www.iovs.org/content/49/12/5526.full

Presence of functional cannabinoid receptors in human endocrine pancreas. (abst – 2008)

http://www.ncbi.nlm.nih.gov/pubmed/18092149
263

Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955420/?tool=pubmed

Cannabinoids as novel anti-inflammatory drugs. (full - 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/?tool=pubmed

Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688760/?tool=pubmed

The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770455/?tool=pmcentrez

Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19345076/abstract/Biological_effects_of_THC_an d_a_lipophilic_cannabis_extract_on_normal_and_insulin_resistant_3T3_L1_adipocytes_

Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19131941

Beneficial effects of a Cannabis sativa extract on diabetes induced neuropathy and oxidative stress. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19441010/abstract/Beneficial_effects_of_a_Canna bis_sativa_extract_treatment_on_diabetes_induced_neuropathy_and_oxidative_stress_

Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug (news – 2009) http://www.thefreelibrary.com/Cannabis+plant+extracts+could+potentially+form+the+basic+ingredients...- a0202701009

Expression and function of cannabinoid receptors in mouse islets. ( full – 2010)

http://www.landesbioscience.com/journals/islets/LiISLETS2-5.pdf

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy (full – 2010) http://diabetes.diabetesjournals.org/content/59/4/1046.full?sid=0bc8e3fa-5275-4b19-8acc-4aec5dfac384
264

Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells (full – 2010) http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=320527&Ausgabe=25 4555&ProduktNr=224332&filename=320527.pdf

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients (full - 2010) http://www.lipidworld.com/content/9/1/43

Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. (full – 2010) http://diabetes.diabetesjournals.org/content/59/11/2826.long#sec-25

Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes. (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925907/?tool=pubmed

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy (full - 2010) http://www.natap.org/2010/newsUpdates/marijuana.pdf

Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes? (full – 2010) http://www.jci.org/articles/view/44099?search[abstract_text]=&search[article_text]=cannabinoid&search[a uthors_text]=&search[fpage]=&search[title_text]=&search[volume]=

Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20937249

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20816753

Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. (abst – 2010) http://www.springerlink.com/content/g037q1lh40l15161/

GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21094910

Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation. (abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/21537423/abstract/Diabetic_retinopathy:_Role_of_ inflammation_and_potential_therapies_for_anti_inflammation_

Pot Compound Mitigates Diabetic Cardiomyopathy (news - 2010)

http://www.norml.org/index.cfm?Group_ID=8424
265
 

momofthegoons

Vapor Accessory Addict
Staff member

Pages 266 - 270


Cannabinoids inhibit and may prevent neuropathic pain in diabetes. (news - 2010)

http://medigardens.blogspot.com/2010/04/march-2010-cannabinoids-inhibit-and-may.html

Lab Notes: Pot Has Benefits for Diabetic Hearts (news - 2010)

http://www.medpagetoday.com/LabNotes/LabNotes/23853

Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice (full– 2011)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082575/?tool=pubmed

Role for cannabinoid receptors in human proximal tubular hypertrophy. (full– 2011)

http://content.karger.com/produktedb/produkte.asp?DOI=000323997&typ=pdf

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21144973/abstract/Cannabidiol_attenuates_cardiac _dysfunction_oxidative_stress_fibrosis_and_inflammatory_and_cell_death_signaling_pathways_in_diabeti c_cardiomyopathy_

Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis (abst – 2011) http://diabetes.diabetesjournals.org/content/60/4/1055.abstract

Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells (abst – 2011)

http://diabetes.diabetesjournals.org/content/60/4/1198.abstract?sid=0bc8e3fa-5275-4b19-8acc- 4aec5dfac384

Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21340622

Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21564460/abstract/Cannabinoid_receptor_agonists _and_antagonists_stimulate_insulin_secretion_from_isolated_human_islets_of_Langerhans_

A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21885477

Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21810593

Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21484568/abstract/Cannabinoids_and_Endocannab inoids_in_Metabolic_Disorders_with_Focus_on_Diabetes_

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21238581
266

Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21309057/abstract/Win_55212_2_reduces_cardiac _ischaemia_reperfusion_injury_in_zucker_diabetic_fatty_rats:_role_of_cb2_receptors_and_cardiac_inos/e nos_expression_

GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (abst – 2011) http://endo.endojournals.org/content/152/2/374.abstract?sid=c77be354-b90f-4368-9bb3-fea533824b24

Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation (abst - 2011) http://abstracts.iovs.org/cgi/content/abstract/52/6/1002?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT

The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22029844

The Endocannabinoid System: Plant-Derived Cannabinoids in Diabetes and Diabetic Complications. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22155112

Takeda moves potential first-in-class diabetes drug into phase III (news – 2011)

http://www.inpharm.com/news/166980/takeda-diabetes-tak-875-phase-iii

DOWN’S SYNDROME

Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18068305

DRIVING AND CANNABIS

Comparison of the Effects of Marijuana and Alcohol on Simulated Driving Performance (full - 1969) http://www.onlinepot.org/medical/Dr_Tods_PDFs/s4_4.pdf

Simulated Flying Performance After Marihuana Intoxication. (abst – 1976)

http://www.ncbi.nlm.nih.gov/pubmed/1252201

Marijuana effects on simulated flying ability. (abst – 1976)

http://www.ncbi.nlm.nih.gov/pubmed/1267035
267

Abstracts of several studies (absts -1982 - 1998)

http://www.ukcia.org/research/medline/8.htm

The Incidence and Role of Drugs in Fatally Injured Drivers - DOT HS 808 065 (full - 1992) http://science.iowamedicalmarijuana.org/pdfs/driving/doths808065.pdf

Marijuana And Actual Driving Performance (full - 1993)

http://science.iowamedicalmarijuana.org/pdfs/driving/doths808078.pdf

CANNABIS AND ROAD SAFETY: AN OUTLINE OF THE RESEARCH STUDIES TO EXAMINE THE EFFECTS OF CANNABIS ON DRIVING SKILLS AND ON ACTUAL DRIVING PERFORMANCE (full - c.1995) http://www.ukcia.org/research/driving2.htm

Cannabis and driving (abst - 1998) http://www.ukcia.org/research/driving4.html Marijuana, Alcohol and Actual Driving Performance - DOT HS 808 939

(full - 1999) http://science.iowamedicalmarijuana.org/pdfs/driving/doths808939.pdf University Of Toronto Study Shows Marijuana Not A Factor In Driving Accidents

(news - 1999) http://www.sciencedaily.com/releases/1999/03/990325110700.htm The influence of cannabis on driving (full - 2000)

http://www.ukcia.org/research/driving/TRL477.pdf

Cannabis use and traffic accidents in a birth cohort of young adults. (abst – 2001)

http://www.ncbi.nlm.nih.gov/pubmed/11579972

Drivers With THC in their Blood Have Only a Small Increased Risk to Cause an Accident (news - 2005) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=207
Roadside sobriety tests and attitudes toward a regulated cannabis market.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796871/?tool=pubmed

Developing limits for driving under cannabis. (abst - 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17916224

Fitness to drive in spite (because) of THC (abst - 2007)

(full – 2007)

http://www.unboundmedicine.com/medline/ebm/record/17879702/abstract/[Fitness_to_drive_in_spite_ _because__of_THC%5D

Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. (abst - 2008) http://www.ncbi.nlm.nih.gov/pubmed/18460360

Cannabis and Driving: A Scientific and Rational Review (news - 2008)

http://norml.org/index.cfm?Group_ID=7459
268

Marijuana and Driving Not So Dangerous After All (news - 2008)

http://www.autoevolution.com/news/marijuana-and-driving-not-so-dangerous-after-all-2756.html

Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood. (abst - 2008) http://www.ncbi.nlm.nih.gov/pubmed/18190663

The effect of cannabis compared with alcohol on driving. (full - 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722956/?tool=pubmed

Sex Differences in the Effects of Marijuana on Simulated Driving Performance (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033009/?tool=pmcentrez

The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand. (abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20380913/abstract/The_effects_of_cannabis_and_a lcohol_on_simulated_arterial_driving:_Influences_of_driving_experience_and_task_demand_

Study: Marijuana Has Little Effect On Driving (news - 2010)

http://www.wfsb.com/health/23818577/detail.html

Hartford Hospital Studies Effects Of Marijuana Use On Driving Skills
(news - 2010) http://www.ctnow.com/health/hc-marijuana-study0608-20100607,0,5896933.story

Psychomotor Impairing Effects Of Cannabis Are Nominal In Experienced Users, Study Says (news – 2010) http://www.norml.org/index.cfm?Group_ID=8404

Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption (full – 2011)

http://ftp.iza.org/dp6112.pdf

The prevalence of cannabis-involved driving in California. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/22101027/abstract/The_prevalence_of_cannabis_i nvolved_driving_in_California_

Alcohol, psychoactive drugs and fatal road traffic accidents in Norway: a case-control study. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21376919/abstract/Alcohol_psychoactive_drugs_a nd_fatal_road_traffic_accidents_in_Norway:_a_case_control_study_

Study shows medical marijuana laws reduce traffic deaths (news – 2011)

http://www.eurekalert.org/pub_releases/2011-11/uocd-ssm112911.php

Why Medical Marijuana Laws Reduce Traffic Deaths (news - 2011)

http://healthland.time.com/2011/12/02/why-medical-marijuana-laws-reduce-traffic-deaths/

It Turns Out That Smoking Marijuana May Actually Make You A Safer Driver
(news – 2011) http://articles.businessinsider.com/2011-12-19/news/30533159_1_medical-marijuana-beer-sales-traffic- fatalities
269

Colorado‘s 5ng/ml per se DUID bill dies again as new research backs higher thresholds for regular users (news – 2011)

http://stash.norml.org/colorados-5ngml-per-se-duid-bill-dies-again-as-new-research-backs-higher- thresholds-for-regular-users

DRONABINOL – a synthetic THC in sesame oil – also see MARINOL
Dronabinol enhancement of appetite in cancer patients. (abst - 1990)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=149

Recent clinical experience with dronabinol. (abst - 1991)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=90

Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy- induced nausea and vomiting. (abst - 1991) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=28

Dronabinol stimulates appetite and causes weight gain in HIV patients. (abst - 1992)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=20

Dronabinol effects on weight in patients with HIV infection. (abst - 1992)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=45

Effect of dronabinol on nutritional status in HIV infection. (abst - 1993)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=150

Treatment of spasticity in spinal cord injury with dronabinol, a tetrahydrocannabinol derivative. (abst - 1995) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=112

Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease (abst - 1997) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=59

Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol). (abst - 1997) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=35

Abuse potential of dronabinol (Marinol). (abst – 1998)

http://www.ncbi.nlm.nih.gov/pubmed/9692381

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative

systematic review (full - 2001)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC34325/?tool=pmcentrez
270
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 271 - 275

Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. (abst - 2002) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=116

Cannabis and the brain. (full - 2003) http://brain.oxfordjournals.org/cgi/content/full/126/6/1252 Cannabinoid rotation in a young woman with chronic cystitis (abst - 2003)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=115

Safety and efficacy of dronabinol in the treatment of agitation in patients with Alzheimer‘s disease A retrospective chart review (abst - 2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=61

On the application of cannabis in paediatrics and epileptology. (abst - 2003)

http://www.ncbi.nlm.nih.gov/pubmed/15159680

Open-label study of dronabinol in the treatment of refractory agitation in Alzheimer‘s disease: a pilot study (abst - 2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=92

Therapeutic potential of cannabinoids in CNS disease. (abst - 2003)

http://www.ncbi.nlm.nih.gov/pubmed/12617697

MARINOL® (Dronabinol) Capsules (monograph - 2004)

http://www.fda.gov/ohrms/dockets/dockets/05n0479/05N-0479-emc0004-04.pdf

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial (full - 2004) http://www.bmj.com/cgi/content/full/329/7460/253

A Novel Intervention for the Treatment of Gout in an Elderly Rehabilitation Patient in Whom Conventional Treatment was Ineffective (full – 2004) http://www.medicine.virginia.edu/clinical/departments/physical-medicine-rehabilitation/Gout-page

Cannabinoid agonists in the treatment of blepharospasm--a case report study. (abst - 2004) http://www.ncbi.nlm.nih.gov/pubmed/15159681

US Patent Application 20060160888 - Room-temperature stable dronabinol formulations (full – 2006) http://www.patentstorm.us/applications/20060160888/fulltext.html

Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension : a case report (abst + 1st page - 2006) http://www.liebertonline.com/doi/abs/10.1089/jop.2006.22.68

Dronabinol for supportive therapy in patients with malignant melanoma and liver

metastases. (abst - 2006)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=180
271

Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study (abst - 2006) http://cel.isiknowledge.com/InboundService.do?product=CEL&action=retrieve&SrcApp=Highwire&UT=0 00239661000005&SID=2BiIeEJCIN8n7IfjpEB&Init=Yes&SrcAuth=Highwire&mode=FullRecord&custo mersID=Highwire

ACG: Cannabinoid Activator Mellows Out Colon (news - 2006)

http://www.medpagetoday.com/MeetingCoverage/ACG/tb/4410

Cannabis Chemicals May Alleviate Post-Eating Stomach Cramps (news – 2006)

http://www.bio-medicine.org/medicine-news/Cannabis-Chemicals-May-Alleviate-Post-Eating-Stomach- Cramps-15219-1/

Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study (full - 2007) http://ajpgi.physiology.org/cgi/content/full/293/1/G137

US Patent Application 20070020193 - Dronabinol compositions and methods for using same (full – 2007) http://www.patentstorm.us/applications/20070020193/fulltext.html

Dronabinol an effective appetite stimulant? A pilot study (abst - 2007)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=188

Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17566383

Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep. (abst - 2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=190

Dronabinol and retinal hemodynamics in humans. (abst - 2007)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=202

Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances. (abst - 2007) http://www.ncbi.nlm.nih.gov/pubmed/17868014

Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. (abst - 2007) http://marijuana.researchtoday.net/archive/4/8/1234.htm

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. (abst - 2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=191

Cannabinoids in the management of difficult to treat pain (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/?tool=pmcentrez

Current Status of Cannabis Treatment of Multiple Sclerosis with an Illustrative Case Presentation of a Patient with MS, Complex Vocal Tics, Paroxysmal Dystonia, and Marijuana Dependence Treated with Dronabinol. (full - 2008) http://medicalcannabis.com/images/pdf09/indications/ms/deutsch_et_al_2008.pdf
272

US Patent Application 20080112895 - Aqueous dronabinol formulations (full – 2008)

http://www.patentstorm.us/applications/20080112895/fulltext.html

Improvement in Refractory Obsessive Compulsive Disorder With Dronabinol (letter- 2008) http://ajp.psychiatryonline.org/cgi/content/full/165/4/536

Emerging strategies for exploiting cannabinoid receptor agonists as medicines. (full – 2009)
http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2008.00048.x/full

Cluster attacks responsive to recreational cannabis and dronabinol. (abst - 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19220500

Effects of {Delta}9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19406854/abstract/Effects_of_{Delta}9_tet rahydrocannabinol_on_reward_and_anxiety_in_rats_exposed_to_chronic_unpredictable_stress_

Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19440079/abstract/

The FDA has written documentation that patients can overdose on Marinol and that it can be lethal (news - 2009) http://www.examiner.com/examiner/x-19678-Cannabis-Revolution-Examiner~y2009m10d23-The-FDA- has-written-documentation-that-patients-can-overdose-on-Marinol-and-that-it-can-be-lethal

Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child (full – 2010) http://www.cannabis-med.org/data/pdf/en_2010_04_1.pdf

Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815025/?tool=pubmed

Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313

Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=316

Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21590520/abstract/Dronabinol_a_cannabinoid_ago nist_reduces_hair_pulling_in_trichotillomania:_a_pilot_study_

Cannabinoids in children (abst – 2011)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
273

Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21803011

Drunk versus drugged: How different are the drivers? (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21925803

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21310551/abstract/Dronabinol_for_the_treatment_ of_cannabis_dependence:_a_randomized_double_blind_placebo_controlled_trial_

Science: THC effective in trichotillomania symptoms in a pilot study (news – 2011)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=348

DRUG INTERACTIONS - see INTERACTIONS WITH OTHER DRUGS

DRUG TESTING

Legal and ethical aspects of drug testing. (full - 1989)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1807765/?tool=pmcentrez&page=1

Interference of Common Household Chemicals in Immunoassay Methods for Drugs of Abuse (full - 1989) http://www.clinchem.org/cgi/reprint/35/4/648?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cann abinoid&searchid=1&FIRSTINDEX=1440&resourcetype=HWCIT

Passive inhalation of cannabis smoke: a novel defence strategy? (abst - 1996)

http://www.ncbi.nlm.nih.gov/pubmed/15335617

GC-MS analysis of the total delta9-THC content of both drug- and fiber-type cannabis seeds. (abst – 2000) http://www.ncbi.nlm.nih.gov/sites/entrez/11110027?dopt=Abstract&holding=f1000,f1000m,isrctn

Consumption and quantitation of delta9-tetrahydrocannabinol in commercially available hemp seed oil products. (abst – 2000) http://www.ncbi.nlm.nih.gov/pubmed/11043660

Toxicological Screening for Drugs of Abuse in Samples Adulterated with Household Chemicals. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12197198
274

Practical Challenges to Positive Drug Tests for Marijuana (editorial - 2003)

http://www.clinchem.org/cgi/content/full/49/7/1037

A Review of Internet-Based Home Drug-Testing Products for Parents (full - 2004)

http://pediatrics.aappublications.org/cgi/content/full/113/4/720?maxtoshow=&hits=80&RESULTFORMA T=&fulltext=cannabis&searchid=1&FIRSTINDEX=1920&resourcetype=HWCIT

Drug testing in the workplace (full - 2004)

http://www.ukcia.org/research/DrugTestingInWorkplace.pdf

Passive Inhalation of Cannabis Smoke. (abst – 2004)

http://www.ncbi.nlm.nih.gov/pubmed/6149279

Drugs of Abuse: Analyses and Ingested Agents That Can Induce Interference or Cross- Reactivity (full - 2006) http://labmed.ascpjournals.org/content/37/6/358.full.pdf+html?maxtoshow=&hits=80&RESULTFORMAT =&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2400&resourcetype=HWCIT

Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16628124

The Effects of Adulterants and Selected Ingested Compounds on Drugs-of-Abuse Testing in Urine (full - 2007) http://ajcp.ascpjournals.org/content/128/3/491.full.pdf+html
Human Cannabinoid Pharmacokinetics (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/?tool=pmcentrez

Roadside sobriety tests and attitudes toward a regulated cannabis market.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796871/?tool=pubmed

Urine drug test interpretation: what do physicians know? (abst - 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17520987

(full – 2007)
Toxicity From the Use of Niacin to Beat Urine Drug Screening (abst - 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17418450

Misusing Vitamin To Foil Drug Test May Be Toxic; Plus, It Doesn't Work (news - 2007) http://www.sciencedaily.com/releases/2007/04/070410162457.htm

Biomarkers for the effects of cannabis and THC in healthy volunteers (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668079/?tool=pmcentrez

Drug-Test Cheats Try New Tricks on Labs (news - 2008)

http://www.webmd.com/mental-health/news/20080728/drug-test-cheats-try-new-tricks-on-labs

Reintoxication: the release of fat-stored Delta-tetrahydrocannabinol (THC) into blood is

enhanced by food deprivation or ACTH exposure. (full - 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782342/?tool=pubmed
275
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 276 - 280

Passive inhalation of cannabis smoke--is it detectable? (abst - 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19151803

Testing for cannabis in the work-place: a review of the evidence. (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20402984

Just Say ̳No‘ to Drug Tests — Then Bargain (news - 2010)

http://labornotes.org/2010/02/just-say-no-drug-tests-then-bargain

Has the Most Common Marijuana Test Resulted in Tens of Thousands of Wrongful Convictions? (news – 2010) http://www.alternet.org/investigations/147613/has_the_most_common_marijuana_test_resulted_in_tens_of _thousands_of_wrongful_convictions/?page=entire

APA: Drug Test Results Often Flawed (news - 2010)

http://www.medpagetoday.com/MeetingCoverage/APA/20253

Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH- THC), and 11-nor-9-carboxy-THC (THCCOOH). (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21764230

A preliminary investigation on the distribution of cannabinoids in man. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21570784/abstract/A_preliminary_investigation_o n_the_distribution_of_cannabinoids_in_man_

Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20529459

Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21381415/abstract/[Simultaneous_determinati on_of_delta_9_tetrahydrocannabinol_cannabidiol_and_cannabinol_in_edible_oil_using_ultra_performance _liquid_chromatography_tandem_mass_spectrometry%5D_

Cannabinoids in postmortem toxicology. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21871147

Immunochemical approach using monoclonal antibody against Δ(9)- tetrahydrocannabinolic acid (THCA) to discern cannabis plants and to investigate new drug candidates. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21143135/abstract/Immunochemical_approach_usi ng_monoclonal_antibody_against_%CE%94_9__tetrahydrocannabinolic_acid__THCA__to_discern_canna bis_plants_and_to_investigate_new_drug_candidates_

New tests for 'legal marijuana,' 'bath salts' and other emerging designer drugs
(news – 2011) http://www.physorg.com/news/2011-08-legal-marijuana-salts-emerging-drugs.html
276

DRUG TESTING - BLOOD


Delta-9-tetrahydrocannabinol: Metabolism and Disposition in Long-term Marihuana Smokers. (abst – 1971) http://medical-journals.healia.com/doc/5087483/Delta-9-tetrahydrocannabinol-metabolism-and-disposition- in-long-term-marihuana-smokers

Stability of delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9- carboxy-THC in blood and plasma. (abst – 1984) http://www.ncbi.nlm.nih.gov/pubmed/6094914

Tetrahydrocannabinol stability in whole blood: plastic versus glass containers. (abst – 1986) http://www.ncbi.nlm.nih.gov/pubmed/3018361

Serum cannabinoid levels 24 to 48 hours after cannabis smoking (abst – 2003)

http://www.ncbi.nlm.nih.gov/pubmed/14639811

Estimating the Time of Last Cannabis Use from Plasma {Delta}9-Tetrahydrocannabinol and 11-nor-9-Carboxy-{Delta}9-Tetrahydrocannabinol Concentrations (full - 2005) http://www.clinchem.org/cgi/content/full/51/12/2289

Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood. (abst - 2008) http://www.ncbi.nlm.nih.gov/pubmed/18190663

Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18334100

Simultaneous analysis of THC and its metabolites in blood using liquid chromatography- tandem mass spectrometry. (abst - 2008) http://www.ncbi.nlm.nih.gov/pubmed/18922747

Do Delta(9)-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784185/?tool=pmcentrez

A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood. (abst - 2009)

http://www.unboundmedicine.com/medline/ebm/record/19630026/abstract/A_semi_automated_solid_phas e_extraction_liquid_chromatography/tandem_mass_spectrometry_method_for_the_analysis_of_tetrahydro cannabinol_and_metabolites_in_whole_blood_

Identification of Recent Cannabis Use:Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics Following Controlled Smoked Cannabis Administration. (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/21836075
277

Quantitation of Total 11-Nor-9-Carboxy-Delta 9-Tetrahydrocannabinol in Urine and Blood Using Gas Chromatography-Mass Spectrometry (GC-MS). (abst - 2010) http://marijuana.researchtoday.net/archive/7/1/2746.htm

Concentrations of delta9-tetrahydrocannabinol and 11-nor-9- carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20465865

Interpretation of blood analysis data found after passive exposure to cannabis
(abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20506708/abstract/[Interpretation_of_blood_a nalysis_data_found_after_passive_exposure_to_cannabis%5D_

Testing for cannabis in the work-place: a review of the evidence. (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20402984

Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral {Delta}9-Tetrahydrocannabinol Administration. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21875944

Identification of Recent Cannabis Use:Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics Following Controlled Smoked Cannabis Administration. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21836075

Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral {Delta}9-Tetrahydrocannabinol Administration. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21875944

Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21116612

Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21078841/abstract/Plasma_cannabinoid_pharmaco kinetics_following_controlled_oral_delta9_tetrahydrocannabinol_and_oromucosal_cannabis_extract_admi nistration_

Variability of cannabinoid findings in blood (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21850885

Latest blood test detects 12 popular synthetic cannabinoids in "fake pot". (news – 2011)

http://www.thefreelibrary.com/Latest+blood+test+detects+12+popular+synthetic+cannabinoids+in+"fa ke...-a0261876557

Colorado‘s 5ng/ml per se DUID bill dies again as new research backs higher thresholds for regular users (news – 2011) http://stash.norml.org/colorados-5ngml-per-se-duid-bill-dies-again-as-new-research-backs-higher- thresholds-for-regular-users
278

DRUG TESTING – BREATH TEST


Detection of δ(9)-tetrahydrocannabinol in exhaled breath collected from cannabis users. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22004672

DRUG TESTING - HAIR

Testing human hair for cannabis (abst - 1995)

http://www.ncbi.nlm.nih.gov/pubmed/7860029

Drugs in Prehistory: Chemical Analysis of Ancient Human Hair.

http://www.fsijournal.org/article/S0379-0738(99)00204-2/abstract

(abst – 1998)
Are cannabinoids detected in hair after washing with Cannabio shampoo? (abst - 1999)

http://www.ncbi.nlm.nih.gov/pubmed/10488922?ordinalpos=101&itool=EntrezSystem2.PEntrez.Pubmed.P ubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Stability of Cannabinoids in Hair Samples Exposed to Sunlight (full - 2000)

http://www.clinchem.org/cgi/content/full/46/11/1846?maxtoshow=&hits=80&RESULTFORMAT=&fullte xt=cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT

Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse (full - 2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1721515/pdf/v088p00F98.pdf/?tool=pmcentrez

Weather-induced changes in cannabinoid content of hair (abst - 2003)

http://www.ncbi.nlm.nih.gov/pubmed/12635486?ordinalpos=68&itool=EntrezSystem2.PEntrez.Pubmed.Pu bmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Assessing the potential of a "color effect" for hair analysis of 11-nor-9-carboxy-delta(9)- tetrahydrocannabinol: analysis of a large sample of hair specimens. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/14609724

Cannabinoids in hair: strategy to prove marijuana/hashish consumption (abst - 2004)

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T6W-4CVV8RB- 1&_user=10&_origUdi=B6X0P-4XMKB9S- 4&_fmt=high&_coverDate=10%2F29%2F2004&_rdoc=1&_orig=article&_acct=C000050221&_version= 1&_urlVersion=0&_userid=10&md5=ad356393e1039ca52b02f10f1f55a794

Deposition of cannabinoids in hair after long-term use of cannabis (abst - 2006)

http://www.ncbi.nlm.nih.gov/pubmed/17098389
279

Cannabinoid concentrations in hair from documented cannabis users. (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2274831/

Differentiation between drug use and environmental contamination when testing for drugs in hair (abst - 2007) http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T6W-4R2GRYJ- 1&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlV ersion=0&_userid=10&md5=03a3594850e79c7c2dad1bd10fb041bf

Evaluation of the IDS One-StepTM ELISA kits for the detection of illicit drugs in hair (abst - 2007) http://www.ncbi.nlm.nih.gov/pubmed/17628371

Hair analysis for Delta9-tetrahydrocannabinolic acid A--new insights into the mechanism of drug incorporation of cannabinoids into hair. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20129747

11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid ethyl ester (THC-COOEt): unsuccessful search for a marker of combined cannabis and alcohol consumption.

(abst – 2010)

http://www.unboundmedicine.com/medline/ebm/record/20074877/abstract/11_nor_Delta9_tetrahydrocanna binol_9_carboxylic_acid_ethyl_ester__THC_COOEt_:_unsuccessful_search_for_a_marker_of_combined_ cannabis_and_alcohol_consumption_

A study on the concentrations of 11-nor-Δ(9)-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in hair root and whole hair. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21497466

A comparative study on the concentrations of 11-nor-Δ(9)-tetrahydrocannabinol-9- carboxylic acid (THCCOOH) in head and pubic hair. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21802874

Detection and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in hair by GC/MS/MS in Negative Chemical Ionization mode (NCI) with a simple and rapid liquid/liquid extraction (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/22036308/abstract/Detection_and_quantification_o f_11_nor_%CE%949_tetrahydrocannabinol_9_carboxylic_acid_in_hair_by_GC/MS/MS_in_Negative_Che mical_Ionization_mode__NCI__with_a_simple_and_rapid_liquid/liquid_extraction_

The standardization of results on hair testing for drugs of abuse: An interlaboratory exercise in Lombardy Region, Italy. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/22018743/abstract/The_standardization_of_results _on_hair_testing_for_drugs_of_abuse:_An_interlaboratory_exercise_in_Lombardy_Region_Italy_
280
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 281 - 285

DRUG TESTING
- OTHER

Nail Analysis for Drugs of Abuse: Extraction and Determination of Cannabis in Fingernails by Ria and Gc-ms. (full – 1999)
http://docstore.ingenta.com/cgi- bin/ds_deliver/1/u/d/ISIS/66686566.1/pres/jat/1999/00000023/00000003/art00003/2AC5C11351BA9FDF1 326514445561BD47516919757.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf

Wiping Up the Evidence (news - 2000)

http://www.webmd.com/news/20000626/wiping-up-drug-evidence

Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse (full - 2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1721515/pdf/v088p00F98.pdf

Prevalence of Illicit Drug Use in Plasmapheresis Donors. (abst – 2003)

http://onlinelibrary.wiley.com/doi/10.1046/j.1423-0410.2003.00264.x/abstract

Usefulness of Sweat Testing for the Detection of Cannabis Smoke (full - 2004)

http://www.clinchem.org/cgi/content/full/50/11/1961

Determination of the prevalence of drug misuse by meconium analysis (full - 2006)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672735/?tool=pubmed

Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. (abst - 2007) http://www.ncbi.nlm.nih.gov/pubmed/17953730

Excretion of Δ9-tetrahydrocannabinol in sweat (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2277330/?tool=pubmed

Drugs of abuse in airborne particulates in urban environments. (abst – 2010)

http://www.unboundmedicine.com/medline/ebm/record/20447692/abstract/Drugs_of_abuse_in_airborne_p articulates_in_urban_environments_

Versatile new ion source for the analysis of materials in open air under ambient conditions. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20655111/abstract/Evaluation_of_drugs_of_abuse _use_and_trends_in_a_prison_through_wastewater_analysis_

DRUG TESTING - ORAL

Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme

cannabis smoke exposure in a motor vehicle. (abst – 2005)

http://www.ncbi.nlm.nih.gov/pubmed/16419389
281

Drug Testing in Oral Fluid (full - 2006)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1579288/?tool=pmcentrez

Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16854544

Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16842950

Interpretation of Oral Fluid Tests for Drugs of Abuse (full - 2007)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2700061&tool=pmcentrez

Roadside oral fluid testing: Comparison of the results of Drugwipe tests with laboratory (abst - 2008) http://marijuana.researchtoday.net/archive/5/3/1351.htm

Portable Oral-Fluid Tests Still Unreliable For Pot, Study Says (news - 2008)

http://norml.org/index.cfm?Group_ID=7636

Evaluation of on-site oral fluid screening using Drugwipe-5(+(R)), RapidSTAT((R)) and Drug Test 5000((R)) for the detection of drugs of abuse in drivers. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19913376/full_citation/Evaluation_of_on_site_oral _fluid_screening_using_Drugwipe_5_+_R___RapidSTAT__R___and_Drug_Test_5000__R___for_the_det ection_of_drugs_of_abuse_in_drivers_

Analysis of cannabis in oral fluid specimens by GC-MS with automatic SPE. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/20120601

Method For Detecting 23 Drugs And Medicines In Saliva Developed (news - 2009)

http://www.sciencedaily.com/releases/2009/02/090211122532.htm

Patent 7816143 Oral detection test for cannabinoid use (full -2010)

http://www.patentstorm.us/patents/7816143/fulltext.html

Simultaneous quantification of cannabinoids and metabolites in oral fluid by two- dimensional gas chromatography mass spectrometry. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20083251

Direct detection of Delta9-tetrahydrocannabinol in saliva using a novel homogeneous competitive immunoassay with fluorescence quenching. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20103093

US Patent Application 20110020945 - ORAL DETECTION TEST FOR CANNABINOID USE (full – 2011)

http://www.patentstorm.us/applications/20110020945/fulltext.html

Cannabinoids in oral fluid following passive exposure to marijuana smoke. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21763088
282

Oral Fluid Cannabinoids in Chronic, Daily Cannabis Smokers During Sustained, Monitored Abstinence. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21677094

A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21411382

Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/21637933

Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral {Delta}9-Tetrahydrocannabinol Administration. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21875944

Synthetic cannabinoids in oral fluid. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21871150

DRUG TESTING - URINE

Delta-9-tetrahydrocannabinol: Metabolism and Disposition in Long-term Marihuana Smokers. (abst – 1971) http://medical-journals.healia.com/doc/5087483/Delta-9-tetrahydrocannabinol-metabolism-and-disposition- in-long-term-marihuana-smokers

Confirmation of the Presence of 11-Hydroxy-r 9-Tetrahydrocannabinol in the Urine of Marijuana Smokers (full - 1972) http://ajph.aphapublications.org/cgi/reprint/62/10/1394?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=cannabis&searchid=1&FIRSTINDEX=3760&resourcetype=HWCIT

Detection of cannabis products in urine by radioimmunoassay. (full -1975)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1673774/?tool=pmcentrez&page=1

Homogeneous enzyme immunoassay for cannabinoids in urine. (full - 1978)

http://www.clinchem.org/cgi/reprint/24/1/95

Laboratory verification of ―heavy‖ and ―light‖ users of cannabis (abst - 1981)

http://www.ncbi.nlm.nih.gov/pubmed/6267648

Persistence of Urinary Marijuana Levels After Supervised Abstinence. (abst – 1982)

http://medical-journals.healia.com/doc/6287871/Persistence-of-urinary-marijuana-levels-after-supervised- abstinence
283

Passive inhalation of marihuana smoke and urinary excretion of cannabinoids (abst - 1983) http://www.nature.com/clpt/journal/v34/n1/abs/clpt1983125a.html

Marijuana-Laced Brownies: Behavioral Effects, Physiologic Effects, and Urinalysis in Humans Following Ingestion (full – 1988)
http://docstore.ingenta.com/cgi- bin/ds_deliver/1/u/d/ISIS/66725041.1/pres/jat/1988/00000012/00000004/art00001/326C346C81BA765A1 326770337BF166BCAB593B4E5.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf

Passive Inhalation of Cannabis Smoke. (abst – 2004)

http://www.ncbi.nlm.nih.gov/pubmed/6149279

Excretion patterns of cannabinoid metabolites after last use in a group of chronic users (full - 1985) http://www.nature.com/clpt/journal/v38/n5/pdf/clpt1985226a.pdf

Contact highs and urinary cannabinoid excretion after passive exposure to
marijuana smoke (full - 1986) http://www.nature.com/clpt/journal/v40/n3/pdf/clpt1986171a.pdf

Cannabinoid intake by passive smoking (abst - 1987)

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=3551865&dopt=abstract plus

Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay.
(full – 1990)
http://docstore.ingenta.com/cgi- bin/ds_deliver/1/u/d/ISIS/66605954.1/pres/jat/1990/00000014/00000005/art00003/2C614027ADDC04511 3261723636BEC72FF8764DCD1.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf

Urinalysis and Casual Handling of Marijuana and Cocaine (full – 1991)

http://docstore.ingenta.com/cgi- bin/ds_deliver/1/u/d/ISIS/66605938.1/pres/jat/1991/00000015/00000001/art00012/187C12CCE78236AD1 326172203D304C71EDE83B642.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf

High urinary cannabinoids from a hashish body packer. (abst – 1993)

http://www.ncbi.nlm.nih.gov/pubmed/8309221

Increased detection of marijuana use with a 50 micrograms/L urine screening cutoff. (full - 1994) http://www.clinchem.org/cgi/reprint/40/11/2114

Hemp oil ingestion causes positive urine tests for Δ9-tetrahydrocannabinol carboxylic acid (full - 1997) http://www.druglibrary.org/crl/drugtesting/Constantino et.al 97 Hemp Oil JAnToxicol.p df

A procedure to overcome interferences caused by the adulterant "Klear" in the GC-MS analysis of 11-nor-delta9-THC-9-COOH. (full – 1997)
http://docstore.ingenta.com/cgi- bin/ds_deliver/1/u/d/ISIS/66605696.1/pres/jat/1997/00000021/00000003/art00014/5D767445E9634557132 6170724C29AEA643DCA3F47.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf
284

Excretion of Cannabinoids in Urine After Ingestion of Cannabis Seed Oil. (abst – 1997)

http://medical-journals.healia.com/doc/9288590/Excretion-of-cannabinoids-in-urine-after-ingestion-of- cannabis-seed-oil

Marijuana-positive urine test results from consumption of hemp seeds in food products. (abst – 1997) http://www.ncbi.nlm.nih.gov/pubmed/9323528

Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9- THCCOOH to creatinine ratio study. (abst – 1999) http://www.ncbi.nlm.nih.gov/pubmed/10517562
Adulteration of urine by "Urine Luck".

http://www.clinchem.org/cgi/content/full/45/7/1051

(full – 1999)
Potassium nitrite reaction with 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine in relation to the drug screening analysis (abst - 1999) http://www.ncbi.nlm.nih.gov/pubmed/10486947?ordinalpos=102&itool=EntrezSystem2.PEntrez.Pubmed.P ubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Concentration of Marijuana Metabolites in the Urine After Ingestion of Hemp Seed Tea. (abst - 1999) http://medical-journals.healia.com/doc/10390703/Concentration-of-marijuana-metabolites-in-the-urine- after-ingestion-of-hemp-seed-tea

Cannabinoid mimics in chocolate utilized as an argument in court (abst – 2000)

http://chocolate.org/chocdefence.html

Evaluating the impact of hemp food consumption on workplace drug tests. (abst – 2001) http://www.ncbi.nlm.nih.gov/pubmed/11765026

Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study (abst - 2001) http://www.unboundmedicine.com/medline/ebm/record/11599601/abstract/

Effects of oxidizing adulterants on detection of 11-nor-delta9-THC-9-carboxylic acid in urine. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12423000

Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12451292

Urinary Cannabinoid Detection Times after Controlled Oral Administration of {Delta}9- Tetrahydrocannabinol to Humans (full - 2003) http://www.clinchem.org/cgi/content/full/49/7/1114

Papain: a novel urine adulterant. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/16105251
285
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 286 - 290

Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9- THC-COOH to creatinine ratio study #2. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12742686

Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/14609657

Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11- hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV. (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/15240035

Detection time of regular THC use in urine shorter than often assumed (abst - 2006)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=213

The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine. (full - 2007) http://ajcp.ascpjournals.org/content/128/3/491.long

Simultaneous GC–EI-MS Determination of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9- Tetrahydrocannabinol, and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Human Urine Following Tandem Enzyme-Alkaline Hydrolysis (full - 2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2689549&tool=pmcentrez

Urine drug test interpretation: what do physicians know? (abst - 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17520987

Family physicians' proficiency in urine drug test interpretation. (abst - 2007)

http://www.ncbi.nlm.nih.gov/pubmed/18290585

Toxicity From the Use of Niacin to Beat Urine Drug Screening (abst - 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17418450?log$=activity

Urine Drug Screening: Practical Guide for Clinicians (full - 2008)

http://mayoclinproc.highwire.org/content/83/1/66.full?maxtoshow=&hits=80&RESULTFORMAT=&fullte xt=cannabinoid&searchid=1&FIRSTINDEX=1520&resourcetype=HWCIT

Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2587336/?tool=pubmed

Do Delta(9)-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784185/?tool=pmcentrez

Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users

precludes use as a biomarker of new drug exposure. (full - 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763020/?tool=pubmed
286

Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)- tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use. (letter - 2009)

http://www.unboundmedicine.com/medline/ebm/record/20040136/abstract/Short_communication:_Urinary _excretion_of_11_nor_9_carboxy_Delta_9__tetrahydrocannabinol_in_a_pregnant_woman_following_hea vy_chronic_cannabis_use_

Identifying New Cannabis Use with Urine Creatinine-Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19470219/abstract/Identifying_New_Cannabis_Us e_with_Urine_Creatinine_Normalized_THCCOOH_Concentrations_and_Time_Intervals_Between_Speci men_Collections_

Urinary toxicological screening: Analytical interference between niflumic acid and cannabis. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19716686/abstract/[Urinary_toxicological_scre ening:_Analytical_interference_between_niflumic_acid_and_cannabis_%5D

Evaluation of a Human On-site Urine Multidrug Test for Emergency Use With Dogs (abst - 2009) http://www.jaaha.org/cgi/content/abstract/45/2/59?maxtoshow=&hits=80&RESULTFORMAT=&fulltext= cannabis&searchid=1&FIRSTINDEX=3200&resourcetype=HWCIT

Passive inhalation of cannabis smoke--is it detectable? (abst - 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19151803

Urine Drug Screening: A Valuable Office Procedure (full – 2010)

http://www.aafp.org/afp/2010/0301/p635.html

Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815025/?tool=pubmed

Testing for cannabis in the work-place: a review of the evidence. (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20402984

Quantitation of Total 11-Nor-9-Carboxy-Delta 9-Tetrahydrocannabinol in Urine and Blood Using Gas Chromatography-Mass Spectrometry (GC-MS). (abst - 2010) http://marijuana.researchtoday.net/archive/7/1/2746.htm

Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. (abst - 2010) http://www.unboundmedicine.com/medline/ebm/record/21134021/abstract/Differentiating_new_cannabis_ use_from_residual_urinary_cannabinoid_excretion_in_chronic_daily_cannabis_users_

Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20614687
287

Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20872894

Now, There's a Test for That -- Norchem's "Fake Marijuana" Test Reveals Significantly Increased Abuse of Spice/K2 (news - 2010) http://www.marketwire.com/press-release/Now-Theres-Test-That-Norchems-Fake-Marijuana-Test- Reveals-Significantly-Increased-Abuse-1356247.htm

Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. (full – 2011)
http://docstore.ingenta.com/cgi- bin/ds_deliver/1/u/d/ISIS/66605491.1/pres/jat/2011/00000035/00000007/art00013/33697C59B13F9CFB13 26169859E74280D392B0112D.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf

A method for CP 47, 497 a synthetic non-traditional cannabinoid in human urine using liquid chromatography tandem mass spectrometry. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21233028

Zinc Reduces the Detection of Cocaine, Methamphetamine, and THC by ELISA Urine Testing. (abst – 2011) We need 8 to 11 mg of zinc daily; over 40 mg/day can cause zinc poisoning. http://www.ncbi.nlm.nih.gov/pubmed/21740689

Concentrations of delta9-tetrahydrocannabinol and 11-nor-9- carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/20465865

Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21506519

Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21134021

Efavirenz interference in urine screening immunoassays for tetrahydrocannabinol. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22067092

DYSKINESIA

Beneficial and adverse effects of cannabidiol in a Parkinson patient with sinemet-induced dystonic dyskinesia. (abst - 1985)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=142

The effects of the cannabinoid receptor agonist nabilone on L-DOPA induced dyskinesia

in patients with idiopathic Parkinson's disease (PD). (abst - 1998)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=153
288

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. (abst - 2001) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=54

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. (abst - 2001) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=54

Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12421641

Tardive Dystonia and the Use of Cannabis. (abst – 2010)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=303

Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21029743

Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia (abst - 2011) http://pharmgkb.org/pmid/21266946

The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/20888328/abstract/The_effects_of_cannabinoid_dr ugs_on_abnormal_involuntary_movements_in_dyskinetic_and_non_dyskinetic_6_hydroxydopamine_lesio ned_rats_

DYSTONIA

Tetrahydrocannabinol potentiates reserpine-induced hypokinesia. (abst – 1981)
http://www.ncbi.nlm.nih.gov/pubmed/6273940

Treatment of Meige's syndrome with cannabidiol. (abst - 1984)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=114

Open label evaluation of cannabidiol in dystonic movement disorders.

http://web.acsalaska.net/~warmgun/es017.html

Cannabidiol (CBD) in dystonic movement disorders. (abst - 1986)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=139

(full - 1986)
(+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters. (abst - 1994) http://www.ncbi.nlm.nih.gov/pubmed/7698178
289

Cannabis in movement disorders. (abst - 1999) http://www.ncbi.nlm.nih.gov/pubmed/10627163 A Dramatic Response to Inhaled Cannabis in a Woman with Central Thalamic Pain and

Dystonia (full - 2002) http://www.jpsmjournal.com/article/PIIS0885392402004268/fulltext Experiences with THC-treatment in children and adolescents (abst - 2003)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=80

Cannabinoid agonists in the treatment of blepharospasm--a case report study. (abst - 2004) http://www.ncbi.nlm.nih.gov/pubmed/15159681

Cannabis sativa and dystonia secondary to Wilson's disease. (needs free registration) (abst - 2005) http://www.medscape.com/medline/abstract/15390041

Current Status of Cannabis Treatment of Multiple Sclerosis with an Illustrative Case Presentation of a Patient with MS, Complex Vocal Tics, Paroxysmal Dystonia, and Marijuana Dependence Treated with Dronabinol. (full - 2008) http://medicalcannabis.com/images/pdf09/indications/ms/deutsch_et_al_2008.pdf

Tardive Dystonia and the Use of Cannabis (letter - 2010)

http://www.turkpsikiyatri.com/en/default.aspx?modul=article&id=749

Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21029743

ECZEMA

Hemp Supplement Boosts Body AND Mind (anecdotal/news - 2001)

http://pr.cannazine.co.uk/201006011282/green/eco-news/hemp-supplement-boosts-body-and-mind.html

Skin Complaint Man Grew Cannabis (news/ anecdotal- 2004)

http://www.mapinc.org/drugnews/v04.n1222.a09.html

Want Nice Skin? Then Smoke Cannabis! (news – 2007)

http://news.softpedia.com/news/Want-Nice-Skin-Then-Smoke-Cannabis-56803.shtml

Cannabis helps treat allergic reactions (news - 2007)

http://www.safeaccessnow.org/article.php?id=4768

Cannabis compound reduces skin allergies in mice (news – 2007)

http://www.newscientist.com/article/dn12016-cannabis-compound-reduces-skin-allergies-in-mice.html

Cannabinoids Reduce Skin Inflammation (news - 2007)

http://www.norml.org/index.cfm?Group_ID=7284&wtm_format=print
290
 

momofthegoons

Vapor Accessory Addict
Staff member

Pages 291 - 295


Marijuana Skin Cream? (news - 2007)

http://www.drugfree.org/join-together/drugs/marijuana-skin-cream

Hemp Seed Oil for Skin (news – 2010)

http://www.livestrong.com/article/340189-hemp-seed-oil-for-skin/

The Cannabis Closet: Severe Eczema (anecdotal - 2010)

http://andrewsullivan.theatlantic.com/the_daily_dish/2010/05/the-cannabis-closet-severe-eczema.html

EDEMA

ANTI-EDEMA AND ANALGESIC PROPERTIES OF Δ9- TETRAHYDROCANNABINOL (THC) (abst- 1973) http://jpet.aspetjournals.org/content/186/3/646.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=marihuana&searchid=1&FIRSTINDEX=2160&resourcetype=HWCIT

Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux. (abst - 2007) http://www.ncbi.nlm.nih.gov/pubmed/17643417

EHLERS-DANLOS SYNDROME

Ehlers-Danlos Syndrome (anecdotal/news- 2010)

http://andrewsullivan.theatlantic.com/the_daily_dish/2010/05/the-cannabis-closet-chronic-joint-pain.html

Schneider: Lansing mom says son's legal marijuana use unfairly stigmatized (anecdotal/news - 2010) http://www.lansingstatejournal.com/article/20100628/NEWS01/6280333/1229/portland

ELMIRIC ACIDS - anandamide analogs
The elmiric acids: biologically active anandamide analogs (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621443/?tool=pmcentrez

Potential anti-inflammatory actions of the elmiric (lipoamino) acids (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896102/?tool=pmcentrez
291

ENCEPHALITIS


CB2 receptors in the brain: role in central immune function (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219530/?tool=pmcentrez

Cannabinoid CB2 receptors in human brain inflammation (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219537/

Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez

ENCEPHALOMYELITIS/ EAE - a mouse multiple sclerosis model
Suppression of experimental autoimmune encephalomyelitis by cannabinoids.

(abst – 1997) http://www.ncbi.nlm.nih.gov/pubmed/7852052

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212 (full - 2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC152941/?tool=pmcentrez

Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15953683

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458883/?tool=pmcentrez

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis ( full - 2007) http://brain.oxfordjournals.org/cgi/content/full/awm160v1

Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189718/?tool=pmcentrez

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from

neuroimmune interactions to cell replacement strategies (full - 2007)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2219542&tool=pmcentrez
292

A Cannabinoid CB2 receptor agonist attenuates experimental autoimmune encephalomyelitis (EAE) and reduces MOG-specific T cell proliferation (abst - 2007) http://www.fasebj.org/cgi/content/meeting_abstract/21/6/A1393- c?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=800& resourcetype=HWCIT

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. (full - 2008) http://www.jbc.org/content/283/19/13320.long

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219542/

Cannabinoids in the management of spasticity associated with multiple sclerosis (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626929/?tool=pmcentrez

Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke. (full – 2009)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855650/?tool=pubmed

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic Experimental Autoimmune Encephalomyelitis (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21406188/abstract/Administration_of_2_arachidon oylglycerol_ameliorates_both_acute_and_chronic_Experimental_Autoimmune_Encephalomyelitis_

ENDOCANNABINOIDS - also see ANANDAMIDE, 2-AG,

Cannabinoids (encyclopedia entry) http://www.chemie.de/lexikon/e/Cannabinoids/
Trick or treat from food endocannabinoids? (abst – 1998)

http://www.nature.com/nature/journal/v396/n6712/full/396636a0.html

Brain Chemicals Mimic Marijuana (news - 1997)

http://www.ukcia.org/research/anandami.php

Body's 'cannabis' could hold blood pressure key (news - 1998)

http://www.ukcia.org/research/blood-pressure.php

Cannabis and cannabinoids: pharmacology and rationale for clinical use

http://pharmgkb.org/pmid/10575283

(abst – 1999)
UC Irvine Researchers Demonstrate How Marijuana-Like Chemicals Work In The Brain (news - 1999) http://www.sciencedaily.com/releases/1999/03/990323050735.htm
293

Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson‘s disease (full - 2000) http://www.fasebj.org/cgi/content/full/14/10/1432?maxtoshow=&hits=10&RESULTFORMAT=&fulltext= cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=20&sortspec=relevance&resourcetype=H WCIT

Endocannabinoids control spasticity in a multiple sclerosis model (full - 2000)

http://www.fasebj.org/cgi/reprint/00- 0399fjev1?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&sear chid=1&FIRSTINDEX=10&sortspec=relevance&resourcetype=HWCIT

Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. (abst – 2000) http://www.ncbi.nlm.nih.gov/pubmed/10733937

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation (full - 2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572987/?tool=pmcentrez

The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection. (abst - 2001) http://www.ncbi.nlm.nih.gov/pubmed/11854768?dopt=Abstract

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts. (full – 2002) http://cardiovascres.oxfordjournals.org/content/55/3/619.long

Never fear, cannabinoids are here (article - 2002) http://mcforadhd.free.fr/naturefear.pdf Endocannabinoids in the central nervous system--an overview. (abst - 2002)

http://www.ncbi.nlm.nih.gov/pubmed/12052038

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12393235

Role of Endogenous Cannabinoids in Synaptic Signaling (full - 2003)

http://physrev.physiology.org/cgi/content/full/83/3/1017?maxtoshow=&hits=80&RESULTFORMAT=&ful ltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT

Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction? (full - 2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573769/?tool=pmcentrez

Endocannabinoids protect the rat isolated heart against ischaemia (full - 2003)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573907/?tool=pmcentrez

Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference

and its age-dependent decline in mice (full - 2003)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC298783/?tool=pmcentrez
294

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis (full - 2003)

http://brain.oxfordjournals.org/cgi/content/full/126/10/2191

Endocannabinoids and the regulation of body fat: the smoke is clearing (full - 2003)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166302/?tool=pmcentrez

Effect of maternal under-nutrition on pup body weight and hypothalamic endocannabinoid levels. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12678501

Possible endocannabinoid control of colorectal cancer growth. (abst - 2003)

http://www.ncbi.nlm.nih.gov/pubmed/12949714

Effects of Cannabis Therapy on Endogenous Cannabinoids (full - 2004)

http://www.cmcr.ucsd.edu/geninfo/piomelli_abs.htm

Endocannabinoids and Their Implications for Epilepsy (full - 2004)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1176361&tool=pmcentrez

Endocannabinoids: Getting the message across (full - 2004)

http://www.pnas.org/content/101/23/8512.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=can nabis&searchid=1&FIRSTINDEX=2880&resourcetype=HWCIT

Involvement of cannabinoid receptors in gut motility and visceral perception (full - 2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574910/?tool=pmcentrez

Clinical Endocannabinoid Deficiency (full - 2004)

http://www.freedomtoexhale.com/clinical.pdf

Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension (full - 2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756479/?tool=pmcentrez
Harm reduction-the cannabis paradox (full - 2005)

http://www.harmreductionjournal.com/content/2/1/17

Blood pressure regulation by endocannabinoids and their receptors

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225528/?tool=pmcentrez

(full - 2005)
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 (full - 2005) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1774787&tool=pmcentrez

Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P (full - 2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856307/?tool=pmcentrez

Endocannabinoids in the Regulation of Appetite and Body Weight. (abst - 2005)

http://medical-journals.healia.com/doc/16148436/Endocannabinoids-in-the-regulation-of-appetite-and- body-weight
295
 

momofthegoons

Vapor Accessory Addict
Staff member
Pages 296 - 300

Body's Pot-Like Chemicals May Help Curb Pain (news - 2005)

http://www.webmd.com/pain-management/news/20050622/bodys-pot-like-chemicals-may-help-curb-pain

Body's Own Marijuana-Like Compounds Are Crucial For Stress-Induced Pain Relief (news - 2005) http://www.sciencedaily.com/releases/2005/06/050628064435.htm

Cream with endocannabinoids effective in the treatment of pruritus due to kidney disease (news - 2005) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=207

Endocannabinoids -- The Brain's Cannabis -- Demonstrate Novel Modes Of Action To Stress (news - 2005) http://www.sciencedaily.com/releases/2005/07/050720065810.htm

Multiple sclerosis may disrupt endocannabinoid brain protection mechanism (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458835/?tool=pmcentrez

Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430692/?tool=pubmed

Endocannabinoid overactivity and intestinal inflammation (full - 2006)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856409/?tool=pmcentrez

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458883/?tool=pmcentrez

Endocannabinoids: Multi-scaled, Global Homeostatic Regulators of Cells and Society (abst - 2006) http://knowledgetoday.org/wiki/index.php/ICCS06/70

Endocannabinoids Mediate the Effects of Acute Stress and Corticosterone on Sex Behavior (full – 2007) http://endo.endojournals.org/content/148/2/493.full

Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology (full - 2007) http://www.sciencedirect.com/science/article/pii/S1074552107002062

Endocannabinoids block status epilepticus in cultured hippocampal neurons (full - 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2617750/?tool=pmcentrez

Endocannabinoids and the haematological system (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190025/?tool=pmcentrez

Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in

vivo in cirrhotic rats (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225474/?tool=pmcentrez
296

Human Cannabinoid Pharmacokinetics (full - 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/?tool=pmcentrez

Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher (interview - 2007) http://www.jleukbio.org/cgi/content/full/82/6/1390?maxtoshow=&hits=80&RESULTFORMAT=&fulltext =cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT

Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (Review) (abst- link to full PDF – 2007) http://www.spandidos-publications.com/or/17/4/813

Migraine may be related to under production of cannabinoids (news - 2007)

http://www.illinoisnorml.org/index2.php?option=com_content&do_pdf=1&id=755

New Study Examines 'Brain's Own Marijuana' (news - 2007)

http://www.sciencedaily.com/releases/2007/05/070516191916.htm

Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids (full – 2008) http://www.jbc.org/content/283/13/8065.full

Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376822/?tool=pmcentrez

Endocannabinoids in endocrine and related tumours (full - 2008)

http://erc.endocrinology-journals.org/cgi/reprint/15/2/391.pdf

Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219536/?tool=pmcentrez

Cannabinoids in pancreatic cancer: Correlation with survival and pain (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225529/?tool=pmcentrez

Endocannabinoids, blood pressure and the human heart. (full - 2008).

http://www3.interscience.wiley.com/cgi-bin/fulltext/119409853/HTMLSTART

Inflammation and aging: can endocannabinoids help? (full - 2008)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2408719&tool=pmcentrez

Endocannabinoids and the Control of Energy Homeostasis (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586261/?tool=pmcentrez

Endocannabinoids in the retina: From marijuana to neuroprotection. (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584875/?tool=pmcentrez

Role of cannabinoids and endocannabinoids in cerebral ischemia (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581413/?tool=pmcentrez
297

Loss of cannabinoid receptor 1 accelerates intestinal tumor growth (full - 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2561258/?tool=pubmed

Pain relief with cannabinoids-- the importance of endocannabinoids and cannabinoids for pain therapy (abst - 2008) http://www.ncbi.nlm.nih.gov/pubmed/18671173

Understanding the effects of endogenous cannabinoids (news - 2008)

http://arstechnica.com/science/news/2008/11/understanding-the-effects-of-endogenous-cannabinoids.ars

Marijuana-Inspired Painkiller? New Chemical Pathway Discovered (news - 2008)

http://www.sciencedaily.com/releases/2008/11/081123150249.htm

Endocannabinoids selectively enhance sweet taste (full - 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818929/?tool=pmcentrez

Dynamic regulation of the endocannabinoid system: implications for analgesia (full - 2009) http://www.molecularpain.com/content/5/1/59
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/?tool=pubmed

Endocannabinoids and Their Receptors as Targets for Obesity Therapy

http://endo.endojournals.org/cgi/content/full/150/6/2531#top

Endocannabinoids: Stress, Anxiety, and Fear (full - 2009)

(full - 2009) (full - 2009)
http://neuro.psychiatryonline.org/cgi/content/full/21/2/iv?maxtoshow=&hits=80&RESULTFORMAT=&fu lltext=cannabis&searchid=1&FIRSTINDEX=1120&resourcetype=HWCIT

Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19897083

Endocannabinoids and cardiovascular prevention: real progress?

http://www.pagepress.org/journals/index.php/hi/article/view/1162

Phytocannabinoids and endocannabinoids. (abst - 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19630737

(abst - 2009)

Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/18777572

Endocannabinoid chemical biology: a tool for the development of novel therapies. (abst - 2009) http://www.unboundmedicine.com/medline/ebm/record/19457702/abstract/

Parasitic brain infection, endocannabinoids, and schizophrenia. (abst - 2009)

http://www.unboundmedicine.com/medline/ebm/record/18995970/abstract/Parasitic_brain_infection_endoc annabinoids_and_schizophrenia_
298

The Endocannabinoid Anandamide: From Immunomodulation to Neuroprotection. Implications for Multiple Sclerosis (abst - 2009) http://www.ncbi.nlm.nih.gov/pubmed/19647114

Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19524019

Endocannabinoids, Closely Related To Active Ingredients In Cannabis Plant, Can Promote Pain (news - 2009) http://www.sciencedaily.com/releases/2009/09/090911212404.htm

Human Brains Make Their Own 'Marijuana' (news - 2009)

http://www.sciencedaily.com/releases/2009/04/090420151240.htm

Enhanced Sweet Taste: Endocannabinoids Act Directly on Tongue Taste Receptors (news - 2009) http://www.sciencedaily.com/releases/2009/12/091222104920.htm

R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/

Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975171/?tool=pubmed

Regulation of the Hypothalamic-Pituitary-Adrenal Axis Circadian Rhythm by Endocannabinoids Is Sexually Diergic (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964781/?tool=pmcentrez

Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons (abst – 2010) http://www.jbc.org/content/285/49/38543.abstract

Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20013888

Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20826813

Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. (abst – 2010)

http://www.unboundmedicine.com/medline/ebm/record/19847654/abstract/Non_CB1_non_CB2_receptors _for_endocannabinoids_plant_cannabinoids_and_synthetic_cannabimimetics:_focus_on_G_protein_couple d_receptors_and_transient_receptor_potential_channels_
299

Role of the endocannabinoid system in alcoholic liver disease. (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/21525760

Study shows direct cellular interaction between endocannabinoids and alcohol in the brain (news - 2010) http://www.news-medical.net/news/20100513/Study-shows-direct-cellular-interaction-between- endocannabinoids-and-alcohol-in-the-brain.aspx

Gut feelings about the endocannabinoid system (full – 2011)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full

Dual inhibition of alpha/beta hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons. (full – 2011) http://www.jbc.org/content/early/2011/06/10/jbc.M110.202853.long

Endocannabinoids in liver disease. (full – 2011)

http://onlinelibrary.wiley.com/doi/10.1002/hep.24077/full

Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids—Cannabinoids and Acute Stress Modulate GABA Release (full – 2011) http://www.hindawi.com/journals/ijcb/2011/529851/

ENDOCANNABINOIDS AND TRAUMATIC BRAIN INJURY. (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21418185

Endocannabinoids and the cardiovascular response to stress. (abst - 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21708837

Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21470162/abstract/Targeting_the_Endocannabinod _System_to_Limit_Myocardial_and_Cerebral_Ischemic_and_Reperfusion_Injury_

CANNABINOIDS AND BONE: ENDOCANNABINOIDS MODULATE HUMAN OSTEOCLAST FUNCTION IN VITRO. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21649637

Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention. (abst - 2011) http://www.ncbi.nlm.nih.gov/pubmed/22178327

Endocannabinoid Signaling In Dietary Restriction And Lifespan Extension (news – 2011) http://www.medicalnewstoday.com/releases/225007.php

Study helps explain why fatty foods are complicit in weight gain (news - 2011)

http://www.news-medical.net/news/20110705/Study-helps-explain-why-fatty-foods-are-complicit-in- weight-gain.aspx

Do Deficits in Brain Cannabinoids Contribute to Eating Disorders? (news – 2011) http://www.sciencedaily.com/releases/2011/10/111031115226.htm
300
 

Sponsored by

PuffItUp VapeFully Dynavap Vaposhop
Top